BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64-67. [PMID: 9140396 DOI: 10.1038/ng0597-64] [Cited by in Crossref: 1332] [Cited by in F6Publishing: 1185] [Article Influence: 55.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Wang R, Cai K, He H, Liu Y, Yen J, Wang Z, Xu M, Sun Y, Zhou X, Yin Q, Tang L, Dobrucki IT, Dobrucki LW, Chaney EJ, Boppart SA, Fan TM, Lezmi S, Chen X, Yin L, Cheng J. Selective in vivo metabolic cell-labeling-mediated cancer targeting. Nat Chem Biol 2017;13:415-24. [PMID: 28192414 DOI: 10.1038/nchembio.2297] [Cited by in Crossref: 150] [Cited by in F6Publishing: 138] [Article Influence: 37.5] [Reference Citation Analysis]
2 Cantara S, Capuano S, Formichi C, Pisu M, Capezzone M, Pacini F. Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. Thyroid Res 2010;3:4. [PMID: 20701785 DOI: 10.1186/1756-6614-3-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
3 Chung SH, Woldenberg N, Roth AR, Masamed R, Conlon W, Cohen JG, Joines MM, Patel MK. BRCA and Beyond: Comprehensive Image-rich Review of Hereditary Breast and Gynecologic Cancer Syndromes. RadioGraphics 2020;40:306-25. [DOI: 10.1148/rg.2020190084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 2001;20:6073-83. [PMID: 11593415 DOI: 10.1038/sj.onc.1204736] [Cited by in Crossref: 197] [Cited by in F6Publishing: 191] [Article Influence: 9.9] [Reference Citation Analysis]
5 Uegaki K, Kanamori Y, Kigawa J, Kawaguchi W, Kaneko R, Naniwa J, Takahashi M, Shimada M, Oishi T, Itamochi H, Terakawa N. PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells. Cell Tissue Res 2006;323:523-8. [PMID: 16283392 DOI: 10.1007/s00441-005-0082-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
6 Reifenberger J, Rauch L, Beckmann MW, Megahed M, Ruzicka T, Reifenberger G. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. Br J Dermatol 2003;148:1040-6. [PMID: 12786840 DOI: 10.1046/j.1365-2133.2003.05322.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
7 Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372:2243-2257. [PMID: 26014596 DOI: 10.1056/nejmsr1501341] [Cited by in Crossref: 539] [Cited by in F6Publishing: 284] [Article Influence: 89.8] [Reference Citation Analysis]
8 Sánchez-Puelles C, Calleja-Felipe M, Ouro A, Bougamra G, Arroyo A, Diez I, Erramuzpe A, Cortés J, Martínez-Hernández J, Luján R, Navarrete M, Venero C, Chan A, Morales M, Esteban JA, Knafo S. PTEN Activity Defines an Axis for Plasticity at Cortico-Amygdala Synapses and Influences Social Behavior. Cereb Cortex 2020;30:505-24. [PMID: 31240311 DOI: 10.1093/cercor/bhz103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT, Bouffard JP, Mena H, Burger PC, Eberhart CG. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 2005;64:341-9. [PMID: 15835270 DOI: 10.1093/jnen/64.4.341] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
10 Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Colston KW. Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk. Recent Results Cancer Res. 2003;164:43-54. [PMID: 12899513 DOI: 10.1007/978-3-642-55580-0_3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
11 Yu Y, Dong L, Li D, Chuai S, Wu Z, Zheng X, Cheng Y, Han L, Yu J, Gao M. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer. Sci Rep 2015;5:16129. [PMID: 26530882 DOI: 10.1038/srep16129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
12 Guney K, Ozbilim G, Derin AT, Cetin S. Expression of PTEN protein in patients with laryngeal squamous cell carcinoma. Auris Nasus Larynx 2007;34:481-6. [DOI: 10.1016/j.anl.2007.03.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
13 Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer. 2011;11:289-301. [PMID: 21430697 DOI: 10.1038/nrc3037] [Cited by in Crossref: 526] [Cited by in F6Publishing: 512] [Article Influence: 52.6] [Reference Citation Analysis]
14 Gauthier-Villars M, Gad S, Caux V, Pagès S, Blandy C, Stoppa-Lyonnet D. Genetic testing for breast cancer predisposition. Surg Clin North Am 1999;79:1171-87, xxi. [PMID: 10572557 DOI: 10.1016/s0039-6109(05)70067-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Neychev V, Sadowski SM, Zhu J, Allgaeuer M, Kilian K, Meltzer P, Kebebew E. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report. J Clin Endocrinol Metab 2016;101:353-8. [PMID: 26678657 DOI: 10.1210/jc.2015-3684] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lobo GP, Waite KA, Planchon SM, Romigh T, Nassif NT, Eng C. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function. Hum Mol Genet 2009;18:2851-62. [PMID: 19457929 DOI: 10.1093/hmg/ddp220] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
17 Marsh DJ, Dahia PLM, Coulon V, Zheng Z, Dorion-bonnet F, Call KM, Little R, Lin AY, Eeles RA, Goldstein AM, Hodgson SV, Richardson A, Robinson BG, Weber HC, Longy M, Eng C. Allelic imbalance, including deletion ofPTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with cowden syndrome and germlinePTEN mutation. Genes Chromosom Cancer 1998;21:61-9. [DOI: 10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
18 Migliore L, Migheli F, Spisni R, Coppedè F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011;2011:792362. [PMID: 21490705 DOI: 10.1155/2011/792362] [Cited by in Crossref: 134] [Cited by in F6Publishing: 140] [Article Influence: 13.4] [Reference Citation Analysis]
19 Hata C, Nakaoka H, Xiang Y, Wang D, Yang A, Liu D, Liu F, Zou Q, Wei L, Zheng K, Inoue I, You H. Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors. J Hum Genet 2020;65:577-87. [PMID: 32029870 DOI: 10.1038/s10038-020-0729-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Nosaka R, Yamasaki F, Saito T, Takayasu T, Kolakshyapati M, Amatya VJ, Takeshima Y, Sugiyama K, Kurisu K. Role for loss of nuclear PTEN in a harbinger of brain metastases. Journal of Clinical Neuroscience 2017;44:148-54. [DOI: 10.1016/j.jocn.2017.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Heikkinen T, Greco D, Pelttari LM, Tommiska J, Vahteristo P, Heikkilä P, Blomqvist C, Aittomäki K, Nevanlinna H. Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Res 2011;13:R130. [PMID: 22171747 DOI: 10.1186/bcr3076] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
22 Hafner C, Toll A, Fernández-Casado A, Earl J, Marqués M, Acquadro F, Méndez-Pertuz M, Urioste M, Malats N, Burns JE. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA. 2010;107:20780-20785. [PMID: 21078999 DOI: 10.1073/pnas.1008365107] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
23 Inamura K, Togashi Y, Nomura K, Ninomiya H, Hiramatsu M, Okui M, Satoh Y, Okumura S, Nakagawa K, Tsuchiya E, Ishikawa Y. Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas. Lung Cancer 2007;57:201-6. [DOI: 10.1016/j.lungcan.2007.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
24 Liu H, Radisky DC, Wang F, Bissell MJ. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004;164:603-12. [PMID: 14769856 DOI: 10.1083/jcb.200306090] [Cited by in Crossref: 169] [Cited by in F6Publishing: 161] [Article Influence: 9.9] [Reference Citation Analysis]
25 Nguyen KA, Syed JS, Shuch B. Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass. Urol Clin North Am 2017;44:155-67. [PMID: 28411908 DOI: 10.1016/j.ucl.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sousa B, Moser E, Cardoso F. An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol 2013;717:71-83. [PMID: 23545364 DOI: 10.1016/j.ejphar.2013.03.037] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
27 Yan M, Wang Y, Wong CW, Or PM, Wong KL, Li L, Many AM, Guan H, Khoo US, Chan AM. PTEN PDZ-binding domain suppresses mammary carcinogenesis in the MMTV-PyMT breast cancer model. Cancer Lett 2018;430:67-78. [PMID: 29772266 DOI: 10.1016/j.canlet.2018.05.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J, Yajima N, Horie Y, Hasegawa G, Naito M, Miyazaki J, Suda T, Itoh H, Nakao K, Mak TW, Nakano T, Suzuki A. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 2005;19:2054-2065. [PMID: 16107612 DOI: 10.1101/gad.1308805] [Cited by in Crossref: 213] [Cited by in F6Publishing: 197] [Article Influence: 13.3] [Reference Citation Analysis]
29 Funato Y, Miki H. Reversible oxidation of PRL family protein-tyrosine phosphatases. Methods 2014;65:184-9. [PMID: 23831336 DOI: 10.1016/j.ymeth.2013.06.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
30 Karayi MK, Markham AF. Molecular biology of prostate cancer. Prostate Cancer Prostatic Dis. 2004;7:6-20. [PMID: 14999233 DOI: 10.1038/sj.pcan.4500697] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
31 Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN. The role of mTOR in the management of solid tumors: an overview. Cancer Treat Rev 2009;35:148-59. [PMID: 19013721 DOI: 10.1016/j.ctrv.2008.09.006] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 8.5] [Reference Citation Analysis]
32 Mayo LD, Seo YR, Jackson MW, Smith ML, Guzman JR, Korgaonkar CK, Donner DB. Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified. Journal of Biological Chemistry 2005;280:25953-9. [DOI: 10.1074/jbc.m503026200] [Cited by in Crossref: 104] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
33 Jung S, Gámez-Díaz L, Proietti M, Grimbacher B. "Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology. Front Immunol 2018;9:966. [PMID: 29867948 DOI: 10.3389/fimmu.2018.00966] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
34 Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, Mak TW. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 2001;29:396-403. [PMID: 11726926 DOI: 10.1038/ng782] [Cited by in Crossref: 339] [Cited by in F6Publishing: 330] [Article Influence: 17.0] [Reference Citation Analysis]
35 Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 2012;39:493-9. [PMID: 22486434 DOI: 10.1111/j.1600-0560.2012.01888.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
36 Inoue T, Kobayashi T, Terada N, Shimizu Y, Kamoto T, Ogawa O, Nakamura E. Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells. Expert Review of Endocrinology & Metabolism 2014;2:689-704. [DOI: 10.1586/17446651.2.5.689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Hamilton JA, Stewart LM, Ajayi L, Gray IC, Gray NE, Roberts KG, Watson GJ, Kaisary AV, Snary D. The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers. Br J Cancer 2000;82:1671-6. [PMID: 10817502 DOI: 10.1054/bjoc.2000.1211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
38 Mitsiades N, Fagin JA. Molecular Genetics of Thyroid Cancer. Genetic Diagnosis of Endocrine Disorders. Elsevier; 2010. pp. 117-38. [DOI: 10.1016/b978-0-12-374430-2.00011-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998;63:1743-8. [PMID: 9837827 DOI: 10.1086/302164] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 7.5] [Reference Citation Analysis]
40 Xue L, Chiang L, Kang C, Winoto A. The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint. Eur J Immunol 2008;38:3200-7. [PMID: 18991293 DOI: 10.1002/eji.200838614] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
41 McAuliffe PF, Meric-Bernstam F, Mills GB, Gonzalez-Angulo AM. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis. Clin Breast Cancer 2010;10 Suppl 3:S59-65. [PMID: 21115423 DOI: 10.3816/CBC.2010.s.013] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 8.4] [Reference Citation Analysis]
42 Lumish HS, Steinfeld H, Koval C, Russo D, Levinson E, Wynn J, Duong J, Chung WK. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients. J Genet Couns 2017;26:1116-29. [PMID: 28357778 DOI: 10.1007/s10897-017-0090-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 15.0] [Reference Citation Analysis]
43 Eng C. Constipation, polyps, or cancer? letPTEN predict your future. Am J Med Genet 2003;122A:315-22. [DOI: 10.1002/ajmg.a.20477] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
44 Zhan H, Bai Y, Lv Y, Zhang X, Zhang L, Deng S. Pharmacological mechanism of mylabris in the treatment of leukemia based on bioinformatics and systematic pharmacology. Bioengineered 2021;12:3229-39. [PMID: 34224300 DOI: 10.1080/21655979.2021.1943110] [Reference Citation Analysis]
45 Wappenschmidt B, Wardelmann E, Gehrig A, Schöndorf T, Maass N, Bonatz G, Gassel AM, Pietsch T, Mallmann P, Weber BH, Schmutzler RK. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas. Hum Pathol 2004;35:1260-5. [PMID: 15492994 DOI: 10.1016/j.humpath.2004.06.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
46 Hsu F, Mao Y. The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis. Biochim Biophys Acta 2015;1851:698-710. [PMID: 25264170 DOI: 10.1016/j.bbalip.2014.09.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
47 Bose S, Crane A, Hibshoosh H, Mansukhani M, Sandweis L, Parsons R. Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol 2002;33:405-9. [PMID: 12055674 DOI: 10.1053/hupa.2002.124721] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 5.4] [Reference Citation Analysis]
48 Tang YC, Ho SC, Tan E, Ng AWT, McPherson JR, Goh GYL, Teh BT, Bard F, Rozen SG. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer. Breast Cancer Res 2018;20:22. [PMID: 29566768 DOI: 10.1186/s13058-018-0949-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
49 Ruijter E, van de Kaa C, Miller G, Ruiter D, Debruyne F, Schalken J. Molecular genetics and epidemiology of prostate carcinoma. Endocr Rev 1999;20:22-45. [PMID: 10047972 DOI: 10.1210/edrv.20.1.0356] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 3.5] [Reference Citation Analysis]
50 Li X, Tran KM, Aziz KE, Sorokin AV, Chen J, Wang W. Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. Mol Cell Proteomics 2016;15:3030-44. [PMID: 27432908 DOI: 10.1074/mcp.M116.060277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
51 Starita LM, Ahituv N, Dunham MJ, Kitzman JO, Roth FP, Seelig G, Shendure J, Fowler DM. Variant Interpretation: Functional Assays to the Rescue. Am J Hum Genet 2017;101:315-25. [PMID: 28886340 DOI: 10.1016/j.ajhg.2017.07.014] [Cited by in Crossref: 164] [Cited by in F6Publishing: 118] [Article Influence: 41.0] [Reference Citation Analysis]
52 Rowinsky EK. Targeting the molecular target of rapamycin (mTOR). Curr Opin Oncol. 2004;16:564-575. [PMID: 15627018 DOI: 10.1097/01.cco.0000143964.74936.d1] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 7.1] [Reference Citation Analysis]
53 Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, Park BH, Martin SS, Weber DJ, Bachman KE. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res 2009;69:8275-83. [PMID: 19843859 DOI: 10.1158/0008-5472.CAN-09-1067] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
54 Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000;85:1758-64. [PMID: 10843148 DOI: 10.1210/jcem.85.5.6557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 45] [Article Influence: 0.1] [Reference Citation Analysis]
55 Mcloughlin NM, Mueller C, Grossmann TN. The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein. Cell Chemical Biology 2018;25:19-29. [DOI: 10.1016/j.chembiol.2017.10.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
56 Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ. Suppression of matrix metallopro-teinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene. 2001;20:6669-6678. [PMID: 11709701 DOI: 10.1038/sj.onc.1204799] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 4.2] [Reference Citation Analysis]
57 Giri D, Ittmann M. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Human Pathology 1999;30:419-24. [DOI: 10.1016/s0046-8177(99)90117-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
58 Evans GR, Lalloo F. Development of a Scoring System to Screen for BRCA1/2 Mutations. In: Webb M, editor. Cancer Susceptibility. Totowa: Humana Press; 2010. pp. 237-47. [DOI: 10.1007/978-1-60761-759-4_14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
59 Li D, Gonzalez O, Bachinski LL, Roberts R. Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD. Gene 2000;256:237-43. [PMID: 11054553 DOI: 10.1016/s0378-1119(00)00347-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
60 Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM, Lunardi A, Webster K, Ng C, Newton RH, Knoblauch N, Guarnerio J, Ito K, Turka LA, Beck AH, Pinton P, Bronson RT, Wei W, Pandolfi PP. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 2014;157:595-610. [PMID: 24766807 DOI: 10.1016/j.cell.2014.03.027] [Cited by in Crossref: 167] [Cited by in F6Publishing: 170] [Article Influence: 23.9] [Reference Citation Analysis]
61 Shinde SR, Maddika S. PTEN Regulates Glucose Transporter Recycling by Impairing SNX27 Retromer Assembly. Cell Rep 2017;21:1655-66. [PMID: 29117568 DOI: 10.1016/j.celrep.2017.10.053] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
62 Ballas M, Sathornsumetee S, Rich J, Dennis P. PTEN hamartomatous tumor syndromes. Russell & Rubinstein's Pathology of Tumors of the Nervous System 7Ed. CRC Press; 2006. pp. 971-7. [DOI: 10.1201/b13439-64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Kurian AW, Hartman AR, Mills MA, Ford JM, Daniel BL, Plevritis SK. Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect 2005;8:221-33. [PMID: 16098152 DOI: 10.1111/j.1369-7625.2005.00333.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
64 Shankar A, Agrawal N, Sharma M, Pandey A, Girdhar K Pandey M. Role of Protein Tyrosine Phosphatases in Plants. Curr Genomics 2015;16:224-36. [PMID: 26962298 DOI: 10.2174/1389202916666150424234300] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 6.4] [Reference Citation Analysis]
65 Bian P, Hu W, Liu C, Li L. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Arch Biochem Biophys 2020;689:108461. [PMID: 32531316 DOI: 10.1016/j.abb.2020.108461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
66 Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002;277:47928-37. [PMID: 12351634 DOI: 10.1074/jbc.M207509200] [Cited by in Crossref: 254] [Cited by in F6Publishing: 140] [Article Influence: 13.4] [Reference Citation Analysis]
67 Braccini L, Ciraolo E, Martini M, Pirali T, Germena G, Rolfo K, Hirsch E. PI3K keeps the balance between metabolism and cancer. Advances in Biological Regulation 2012;52:389-405. [DOI: 10.1016/j.jbior.2012.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
68 Salmena L. PTEN: History of a Tumor Suppressor. In: Salmena L, Stambolic V, editors. PTEN. New York: Springer; 2016. pp. 3-11. [DOI: 10.1007/978-1-4939-3299-3_1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
69 Jung BC, Arevalo-Perez J, Lyo JK, Holodny AI, Karimi S, Young RJ, Peck KK. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI. J Neuroimaging 2016;26:240-6. [PMID: 26235208 DOI: 10.1111/jon.12281] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
70 Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK, Durden DL. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci U S A 2001;98:4622-7. [PMID: 11274365 DOI: 10.1073/pnas.081063798] [Cited by in Crossref: 172] [Cited by in F6Publishing: 155] [Article Influence: 8.6] [Reference Citation Analysis]
71 Mutter GL. Pten, a protean tumor suppressor. Am J Pathol 2001;158:1895-8. [PMID: 11395362 DOI: 10.1016/S0002-9440(10)64656-1] [Cited by in Crossref: 98] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
72 Stratakis CA, Kirschner LS, Taymans SE, Tomlinson IPM, Marsh DJ, Torpy DJ, Giatzakis C, Eccles DM, Theaker J, Houlston RS, Blouin J, Antonarakis SE, Basson CT, Eng C, Carney JA. Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci. The Journal of Clinical Endocrinology & Metabolism 1998;83:2972-6. [DOI: 10.1210/jcem.83.8.5042] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
73 Phadngam S, Castiglioni A, Ferraresi A, Morani F, Follo C, Isidoro C. PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells. Oncotarget 2016;7:84999-5020. [PMID: 27829222 DOI: 10.18632/oncotarget.13113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
74 Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet. 2001;28:184-187. [PMID: 11381269 DOI: 10.1038/88919] [Cited by in Crossref: 429] [Cited by in F6Publishing: 381] [Article Influence: 21.5] [Reference Citation Analysis]
75 Isik E, Simsir OS, Solmaz AE, Onay H, Atik T, Aykut A, Durmaz A, Cogulu O, Ozkinay F. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients. Annals of Human Genetics 2020;84:324-30. [DOI: 10.1111/ahg.12380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Fei G, Ebert MPA, Mawrin C, Leodolter A, Schmidt N, Dietzmann K, Malfertheiner P. Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives: . European Journal of Gastroenterology & Hepatology 2002;14:297-303. [DOI: 10.1097/00042737-200203000-00015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
77 Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 1998;23:239-43. [PMID: 9790504 DOI: 10.1002/(sici)1098-2264(199811)23:3<239::aid-gcc5>3.0.co;2-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
78 Maharjan CK, Ear PH, Tran CG, Howe JR, Chandrasekharan C, Quelle DE. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers (Basel) 2021;13:5117. [PMID: 34680266 DOI: 10.3390/cancers13205117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Peltier J, Lok C, Fichten A, Bruniau A, Lefranc M, Toussaint P, Desenclos C, Le Gars D. Lhermitte-Duclos disease and Cowden's syndrome. Neurochirurgie 2006;52:407-14. [DOI: 10.1016/s0028-3770(06)71239-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
80 Tahmasebi S, Khoutorsky A, Mathews MB, Sonenberg N. Translation deregulation in human disease. Nat Rev Mol Cell Biol 2018;19:791-807. [PMID: 30038383 DOI: 10.1038/s41580-018-0034-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 42.0] [Reference Citation Analysis]
81 Moschetta M, Reale A, Marasco C, Vacca A, Carratù MR. Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations. Br J Pharmacol 2014;171:3801-13. [PMID: 24780124 DOI: 10.1111/bph.12749] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
82 Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Mol Cancer. 2013;12:85. [PMID: 23902739 DOI: 10.1186/1476-4598-12-85] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 10.0] [Reference Citation Analysis]
83 Tsou HC, Teng DH, Ping XL, Brancolini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV, Peacocke M. The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 1997;61:1036-43. [PMID: 9345101 DOI: 10.1086/301607] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 3.1] [Reference Citation Analysis]
84 Furnari FB, Lin H, Huang HS, Cavenee WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A. 1997;94:12479-12484. [PMID: 9356475 DOI: 10.1073/pnas.94.23.12479] [Cited by in Crossref: 276] [Cited by in F6Publishing: 289] [Article Influence: 11.5] [Reference Citation Analysis]
85 Atta IS, AlQahtani FN. Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence. Case Rep Med 2016;2016:2928084. [PMID: 27087812 DOI: 10.1155/2016/2928084] [Reference Citation Analysis]
86 Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, Eng C, Ringel MD, Kloos RT. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid 2011;21:505-10. [PMID: 21417916 DOI: 10.1089/thy.2010.0365] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
87 Laug� A, Lefebvre C, Laurent-puig P, Caux V, Gad S, Eng C, Longy M, Stoppa-lyonnet D. No evidence for germlinePTEN mutations in families with breast and brain tumours. Int J Cancer 1999;84:216-9. [DOI: 10.1002/(sici)1097-0215(19990621)84:3<216::aid-ijc3>3.0.co;2-e] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
88 Winter SF, Hunter KW. Mouse modifier genes in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 2008;13:337-42. [PMID: 18661105 DOI: 10.1007/s10911-008-9089-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
89 Darling TN. Hitting the mark in hamartoma syndromes. Adv Dermatol 2006;22:181-200. [PMID: 17249302 DOI: 10.1016/j.yadr.2006.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
90 Zhang L, Yu Q, He J, Zha X. Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines. Mol Cell Biochem. 2004;262:25-33. [PMID: 15532706 DOI: 10.1023/B:MCBI.0000038212.78008.7f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
91 Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, Deluca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu F, Tsao M, Mak TW. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-73. [DOI: 10.1016/j.ccr.2005.02.010] [Cited by in Crossref: 387] [Cited by in F6Publishing: 376] [Article Influence: 24.2] [Reference Citation Analysis]
92 Guigon CJ, Zhao L, Willingham MC, Cheng SY. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene 2009;28:509-17. [PMID: 18997818 DOI: 10.1038/onc.2008.407] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
93 Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 2002;27:462-7. [PMID: 12217521 DOI: 10.1016/s0968-0004(02)02166-7] [Cited by in Crossref: 270] [Cited by in F6Publishing: 122] [Article Influence: 14.2] [Reference Citation Analysis]
94 Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA. 1998;95:5246-5250. [PMID: 9560261 DOI: 10.1073/pnas.95.9.5246] [Cited by in Crossref: 418] [Cited by in F6Publishing: 399] [Article Influence: 18.2] [Reference Citation Analysis]
95 Stumpf M, den Hertog J. Differential Requirement for Pten Lipid and Protein Phosphatase Activity during Zebrafish Embryonic Development. PLoS One 2016;11:e0148508. [PMID: 26848951 DOI: 10.1371/journal.pone.0148508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
96 Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127-150. [PMID: 18767981 DOI: 10.1146/annurev.pathol.4.110807.092311] [Cited by in Crossref: 723] [Cited by in F6Publishing: 702] [Article Influence: 60.3] [Reference Citation Analysis]
97 Parsons R. Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT Oncogenes. Cold Spring Harb Perspect Med 2020;10:a036129. [PMID: 31932465 DOI: 10.1101/cshperspect.a036129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
98 Kim SR, Lee YC. PTEN as a unique promising therapeutic target for occupational asthma. Immunopharmacol Immunotoxicol 2008;30:793-814. [PMID: 18671162 DOI: 10.1080/08923970802285164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
99 Gryfe R. Clinical Implications of Our Advancing Knowledge of Colorectal Cancer Genetics: Inherited Syndromes, Prognosis, Prevention, Screening and Therapeutics. Surgical Clinics of North America 2006;86:787-817. [DOI: 10.1016/j.suc.2006.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
100 Kraimps JL, Canzian F, Jost C, Menet E, Amati P, Levillian P, Harach R, Lesueur F, Barbier J, Romeo G, Bonneau D. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery 1999;126:1188-94. [PMID: 10598206 DOI: 10.1067/msy.2099.102606] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
101 Hedenfalk IA, Ringnér M, Trent JM, Borg A. Gene expression in inherited breast cancer. Adv Cancer Res 2002;84:1-34. [PMID: 11883525 DOI: 10.1016/s0065-230x(02)84001-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
102 Ganguly P, Madonsela L, Chao JT, Loewen CJR, O'Connor TP, Verheyen EM, Allan DW. A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. PLoS Genet 2021;17:e1009774. [PMID: 34492006 DOI: 10.1371/journal.pgen.1009774] [Reference Citation Analysis]
103 Pain M, Darbinyan A, Fowkes M, Shrivastava R. Multiple Meningiomas in a Patient with Cowden Syndrome. J Neurol Surg Rep 2016;77:e128-33. [PMID: 27563534 DOI: 10.1055/s-0036-1584265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
104 Chen X, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Rev Anticancer Ther 2006;6:187-96. [PMID: 16445371 DOI: 10.1586/14737140.6.2.187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
105 Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676-689. [PMID: 9497246 DOI: 10.1086/301749] [Cited by in Crossref: 1977] [Cited by in F6Publishing: 1700] [Article Influence: 86.0] [Reference Citation Analysis]
106 Dobyns WB, Mirzaa GM. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR. Am J Med Genet C Semin Med Genet 2019;181:582-90. [PMID: 31441589 DOI: 10.1002/ajmg.c.31736] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
107 Barba G, Matteucci C, Girolomoni G, Brandimarte L, Varasano E, Martelli MF, Mecucci C. Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas. Cancer Genet Cytogenet 2008;184:48-51. [PMID: 18558289 DOI: 10.1016/j.cancergencyto.2008.03.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
108 Chodosh LA, Gardner HP, Rajan JV, Stairs DB, Marquis ST, Leder PA. Protein kinase expression during murine mammary development. Dev Biol 2000;219:259-76. [PMID: 10694421 DOI: 10.1006/dbio.2000.9614] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
109 Garcia JM, Silva J, Pena C, Garcia V, Rodriguez R, Cruz MA, Cantos B, Provencio M, Espana P, Bonilla F. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer. 2004;41:117-124. [PMID: 15287024 DOI: 10.1002/gcc.20062] [Cited by in Crossref: 152] [Cited by in F6Publishing: 149] [Article Influence: 8.9] [Reference Citation Analysis]
110 Gupta R, Ting JT, Sokolov LN, Johnson SA, Luan S. A tumor suppressor homolog, AtPTEN1, is essential for pollen development in Arabidopsis. Plant Cell 2002;14:2495-507. [PMID: 12368500 DOI: 10.1105/tpc.005702] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 5.7] [Reference Citation Analysis]
111 Mehenni H, Friedl W, Nelen MR, Hutter P, Brundler MA. An unexpected Cowden syndrome case found among members of a large familial adenomatous polyposis kindred: . European Journal of Gastroenterology & Hepatology 2005;17:1407-12. [DOI: 10.1097/01.meg.0000184983.38398.b6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Yu R, Bai H, Gao B, Li T, He X, Zhang P, Wang J. Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K/AKT apoptosis-inhibiting pathway. Thorac Cancer. 2021;12:128-132. [PMID: 33225619 DOI: 10.1111/1759-7714.13726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 Vasovcak P, Krepelova A, Puchmajerova A, Spicak J, Voska L, Musilova A, Mestak J, Martinek J. A novel mutation of PTEN gene in a patient with Cowden syndrome with excessive papillomatosis of the lips, discrete cutaneous lesions, and gastrointestinal polyposis: . European Journal of Gastroenterology & Hepatology 2007;19:513-7. [DOI: 10.1097/meg.0b013e3280d6ed4b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
114 Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009;22:198-208. [PMID: 21037810 DOI: 10.1055/s-0029-1242459] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
115 Lymberis SC, Parhar PK, Katsoulakis E, Formenti SC. Pharmacogenomics and breast cancer. Pharmacogenomics 2004;5:31-55. [PMID: 14683419 DOI: 10.1517/phgs.5.1.31.25686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
116 Piccirilli M, Salvati M, Bistazzoni S, Frati A, Brogna C, Giangaspero F, Frati R, Santoro A. Glioblastoma Multiforme and Breast Cancer: Report on 11 Cases and Clinico-Pathological Remarks. Tumori 2005;91:256-60. [DOI: 10.1177/030089160509100309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
117 Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011;3:19-34. [PMID: 22126150 DOI: 10.2217/epi.10.64] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
118 Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum 2005;52:322-32. [PMID: 15641042 DOI: 10.1002/art.20782] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
119 Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc Natl Acad Sci USA. 1998;95:9418-9423. [PMID: 9689095 DOI: 10.1073/pnas.95.16.9418] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 2.8] [Reference Citation Analysis]
120 Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN Gene Alterations in Lymphoid Neoplasms. Blood 1998;92:3410-5. [DOI: 10.1182/blood.v92.9.3410.421a06_3410_3415] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
121 Sun H, Enomoto T, Fujita M, Wada H, Yoshino K, Ozaki K, Nakamura T, Murata Y. Mutational Analysis of the PTEN Gene in Endometrial Carcinoma and Hyperplasia. Am J Clin Pathol 2001;115:32-8. [DOI: 10.1309/7jx6-b9u9-3p0r-eqny] [Cited by in Crossref: 79] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
122 Braud A, de Rocquancourt A, Marty M, Espie M. Cowden disease and Lhermitte Duclos disease, markers of breast carcinoma: Report of two patients. Annals of Oncology 1999;10:1241-3. [DOI: 10.1023/a:1008317923860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
123 Carnero A, Paramio JM. The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models. Front Oncol 2014;4:252. [PMID: 25295225 DOI: 10.3389/fonc.2014.00252] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 13.6] [Reference Citation Analysis]
124 Singh B, Ittmann MM, Krolewski JJ. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosom Cancer 1998;21:166-71. [DOI: 10.1002/(sici)1098-2264(199802)21:2<166::aid-gcc13>3.0.co;2-p] [Cited by in Crossref: 53] [Article Influence: 2.3] [Reference Citation Analysis]
125 Kurland JE, Beck SE, Solomon CJ, Brann OS, Carethers JM, Huang SC. Cyclooxygenase-2 expression in polyps from a patient with juvenile polyposis syndrome with mutant BMPR1A. J Pediatr Gastroenterol Nutr. 2007;44:318-325. [PMID: 17325551 DOI: 10.1097/MPG.0b013e31802e98e5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
126 Montgomery RK, Breault DT. Small intestinal stem cell markers. J Anat. 2008;213:52-58. [PMID: 18638070 DOI: 10.1111/j.1469-7580.2008.00925.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
127 Su T, Chang J, Perng L, Chang C, Wei H, Wang NM, Tsai C. Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Cervical Cancer. Gynecologic Oncology 2000;76:193-9. [DOI: 10.1006/gyno.1999.5659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
128 Kaur A, Sharma S. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Inflammopharmacology 2017;25:293-312. [PMID: 28417246 DOI: 10.1007/s10787-017-0336-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
129 Leung C, Pan S, Shuch B. Management of renal cell carcinoma in young patients and patients with hereditary syndromes. Current Opinion in Urology 2016;26:396-404. [DOI: 10.1097/mou.0000000000000322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
130 Gierach GL, Yang XR, Figueroa JD, Sherman ME. Emerging Concepts in Breast Cancer Risk Prediction. Curr Obstet Gynecol Rep 2013;2:43-52. [DOI: 10.1007/s13669-012-0034-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
131 Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW. Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 1999;82:290-3. [PMID: 10051160 DOI: 10.1002/(sici)1096-8628(19990212)82:4<290::aid-ajmg3>3.0.co;2-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
132 Romero A, Pérez-Segura P, Tosar A, García-Saenz JA, Díaz-Rubio E, Caldés T, de la Hoya M. A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. Breast Cancer Res Treat 2011;129:939-46. [PMID: 21537932 DOI: 10.1007/s10549-011-1543-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
133 Figer A, Kaplan A, Frydman M, Lev D, Paswell J, Papa MZ, Goldman B, Friedman E. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer. Clin Genet 2002;62:298-302. [PMID: 12372056 DOI: 10.1034/j.1399-0004.2002.620407.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
134 Low SK, Zembutsu H, Nakamura Y. Breast cancer: The translation of big genomic data to cancer precision medicine. Cancer Sci 2018;109:497-506. [PMID: 29215763 DOI: 10.1111/cas.13463] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
135 Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci USA. 1999;96:10182-10187. [PMID: 10468583 DOI: 10.1073/pnas.96.18.10182] [Cited by in Crossref: 219] [Cited by in F6Publishing: 230] [Article Influence: 10.0] [Reference Citation Analysis]
136 Rivière JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012;44:934-940. [PMID: 22729224 DOI: 10.1038/ng.2331] [Cited by in Crossref: 450] [Cited by in F6Publishing: 401] [Article Influence: 50.0] [Reference Citation Analysis]
137 Mavros A, Hahn M, Wieland I, Koy S, Koufaki ON, Strelocke K, Koch R, Haroske G, Schackert HK, Eckelt U. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity: Genetic alterations of PTEN/MMAC1 in oral cancer. Journal of Oral Pathology & Medicine 2002;31:270-6. [DOI: 10.1034/j.1600-0714.2002.310504.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
138 Yuan L, Lv Y, Li H, Gao H, Song S, Zhang Y, Xing G, Kong X, Wang L, Li Y, Zhou T, Gao D, Xiao ZX, Yin Y, Wei W, He F, Zhang L. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol 2015;17:1169-81. [PMID: 26280536 DOI: 10.1038/ncb3218] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 10.8] [Reference Citation Analysis]
139 Faucherre A, Taylor GS, Overvoorde J, Dixon JE, Hertog JD. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 2008;27:1079-86. [DOI: 10.1038/sj.onc.1210730] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
140 Hasle N, Matreyek KA, Fowler DM. The Impact of Genetic Variants on PTEN Molecular Functions and Cellular Phenotypes. Cold Spring Harb Perspect Med 2019;9:a036228. [PMID: 31451538 DOI: 10.1101/cshperspect.a036228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
141 Choi JP, Desai R, Zheng Y, Yao M, Dong Q, Watson G, Handelsman DJ, Simanainen U. Androgen actions via androgen receptor promote PTEN inactivation induced uterine cancer. Endocr Relat Cancer 2015;22:687-701. [PMID: 26285813 DOI: 10.1530/ERC-15-0203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
142 Rudge SA, Wakelam MJ. Phosphatidylinositolphosphate phosphatase activities and cancer. J Lipid Res 2016;57:176-92. [PMID: 26302980 DOI: 10.1194/jlr.R059154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
143 Gregorian C, Nakashima J, Le Belle J, Ohab J, Kim R, Liu A, Smith KB, Groszer M, Garcia AD, Sofroniew MV, Carmichael ST, Kornblum HI, Liu X, Wu H. Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci 2009;29:1874-86. [PMID: 19211894 DOI: 10.1523/JNEUROSCI.3095-08.2009] [Cited by in Crossref: 168] [Cited by in F6Publishing: 108] [Article Influence: 14.0] [Reference Citation Analysis]
144 Choorapoikayil S, Weijts B, Kers R, de Bruin A, den Hertog J. Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish. Dis Model Mech 2013;6:1159-66. [PMID: 23720233 DOI: 10.1242/dmm.012377] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
145 Sherman SK, Maxwell JE, Qian Q, Bellizzi AM, Braun TA, Iannettoni MD, Darbro BW, Howe JR. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations. Cancer Genet 2015;208:41-6. [PMID: 25554686 DOI: 10.1016/j.cancergen.2014.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
146 Oldenburg R, Meijers-heijboer H, Cornelisse C, Devilee P. Genetic susceptibility for breast cancer: How many more genes to be found? Critical Reviews in Oncology/Hematology 2007;63:125-49. [DOI: 10.1016/j.critrevonc.2006.12.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
147 Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM. The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome. Breast Cancer Res Treat 2012;136:911-8. [PMID: 23132533 DOI: 10.1007/s10549-012-2322-z] [Reference Citation Analysis]
148 Martinez R, Schackert HK, Appelt H, Plaschke J, Baretton G, Schackert G. Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme. J Cancer Res Clin Oncol 2005;131:87-93. [PMID: 15672285 DOI: 10.1007/s00432-004-0592-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
149 Kim RH, Wang X, Evans AJ, Campbell SC, Nguyen JK, Farncombe KM, Eng C. Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome. NPJ Genom Med 2020;5:40. [PMID: 33083010 DOI: 10.1038/s41525-020-00148-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Hoekstra E, Peppelenbosch MP, Fuhler GM. The role of protein tyrosine phosphatases in colorectal cancer. Biochim Biophys Acta 2012;1826:179-88. [PMID: 22521639 DOI: 10.1016/j.bbcan.2012.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
151 Naguib A, Bencze G, Cho H, Zheng W, Tocilj A, Elkayam E, Faehnle CR, Jaber N, Pratt CP, Chen M, Zong WX, Marks MS, Joshua-Tor L, Pappin DJ, Trotman LC. PTEN functions by recruitment to cytoplasmic vesicles. Mol Cell 2015;58:255-68. [PMID: 25866245 DOI: 10.1016/j.molcel.2015.03.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
152 Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010;28:1075-1083. [PMID: 20085938 DOI: 10.1200/jco.2009.25.3641] [Cited by in Crossref: 857] [Cited by in F6Publishing: 458] [Article Influence: 77.9] [Reference Citation Analysis]
153 Minaguchi T, Yoshikawa H, Nakagawa S, Yasugi T, Yano T, Iwase H, Mizutani K, Shiromizu K, Ohmi K, Watanabe Y, Noda K, Nishiu M, Nakamura Y, Taketani Y. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix. Cancer Letters 2004;210:57-62. [DOI: 10.1016/j.canlet.2004.03.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
154 Cohen MM. Some neoplasms and some hamartomatous syndromes: genetic considerations. International Journal of Oral and Maxillofacial Surgery 1998;27:363-9. [DOI: 10.1016/s0901-5027(98)80066-0] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
155 Eng C, Ji H. Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters. Am J Hum Genet 1998;62:1020-2. [PMID: 9545417 DOI: 10.1086/301847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
156 Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A. Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer. Onco Targets Ther 2014;7:2085-92. [PMID: 25419146 DOI: 10.2147/OTT.S53597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
157 Renner O, Blanco-Aparicio C, Carnero A. Genetic modelling of the PTEN/AKT pathway in cancer research. Clin Transl Oncol 2008;10:618-27. [PMID: 18940742 DOI: 10.1007/s12094-008-0262-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
158 Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C. Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer. Molecular Cell 1999;3:799-804. [DOI: 10.1016/s1097-2765(01)80012-5] [Cited by in Crossref: 362] [Cited by in F6Publishing: 138] [Article Influence: 16.5] [Reference Citation Analysis]
159 Seely BL, Samimi G, Webster NJ. Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo. BMC Cancer. 2002;2:15. [PMID: 12057025 DOI: 10.1186/1471-2407-2-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
160 Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 2004;26:1069-83. [PMID: 15515157 DOI: 10.1002/hed.20099] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
161 High WA, Robinson WA. Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol. 2007;23:61-79. [PMID: 18159896 DOI: 10.1016/j.yadr.2007.07.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
162 Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Molecular neurobiology of mTOR. Neuroscience 2017;341:112-53. [PMID: 27889578 DOI: 10.1016/j.neuroscience.2016.11.017] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 29.4] [Reference Citation Analysis]
163 Stratakis CA. Genetics of Carney Complex and Related Familial Lentiginoses, and other Multiple Tumor Syndromes. Pediatric Pathology & Molecular Medicine 2010;19:41-68. [DOI: 10.1080/15513810009168808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
164 Kulke MH, Odze RD, Thakore KS, Thomas G, Wang H, Loda M, Eng C. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer 2001;84:748-53. [PMID: 11259087 DOI: 10.1054/bjoc.2000.1660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
165 Krishnaswami SR, Kumar S, Ordoukhanian P, Yu BD. Fate and plasticity of the epidermis in response to congenital activation of BRAF. J Invest Dermatol 2015;135:481-9. [PMID: 25202828 DOI: 10.1038/jid.2014.388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
166 Sawada T, Hamano N, Satoh H, Okada T, Takeda Y, Mabuchi H. Mutation analysis of the PTEN / MMAC1 gene in Japanese patients with Cowden disease. Jpn J Cancer Res 2000;91:700-5. [PMID: 10920277 DOI: 10.1111/j.1349-7006.2000.tb01002.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
167 Mazeh H, Sippel RS. Familial nonmedullary thyroid carcinoma. Thyroid 2013;23:1049-56. [PMID: 23734600 DOI: 10.1089/thy.2013.0079] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
168 Sarlis NJ. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects. Rev Endocr Metab Disord 2000;1:183-96. [PMID: 11708296 DOI: 10.1023/a:1010079031162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
169 Stornetta RL, Zhu JJ. Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist 2011;17:54-78. [PMID: 20431046 DOI: 10.1177/1073858410365562] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
170 Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011;96:E2063-E2071. [PMID: 21956414 DOI: 10.1210/jc.2011-1616] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 11.6] [Reference Citation Analysis]
171 Garcia-Junco-Clemente P, Golshani P. PTEN: A master regulator of neuronal structure, function, and plasticity. Commun Integr Biol 2014;7:e28358. [PMID: 24778766 DOI: 10.4161/cib.28358] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
172 Zhang SJ, Endo S, Ichikawa T, Yoshimura J, Onda K, Tanaka R, Washiyama K, Kumanishi T. Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin. Jpn J Cancer Res 1999;90:934-41. [PMID: 10551321 DOI: 10.1111/j.1349-7006.1999.tb00838.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
173 Kunz M, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Mol Cancer. 2003;2:23. [PMID: 12740039 DOI: 10.1186/1476-4598-2-23] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 6.7] [Reference Citation Analysis]
174 Wang Q, Von T, Bronson R, Ruan M, Mu W, Huang A, Maira SM, Zhao JJ. Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome. Genes Dev 2013;27:1568-80. [PMID: 23873941 DOI: 10.1101/gad.216069.113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
175 Leslie NR, Longy M. Inherited PTEN mutations and the prediction of phenotype. Seminars in Cell & Developmental Biology 2016;52:30-8. [DOI: 10.1016/j.semcdb.2016.01.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
176 Inoue T, Ogawa O. Role of signaling transduction pathways in development of castration-resistant prostate cancer. Prostate Cancer 2011;2011:647987. [PMID: 22110995 DOI: 10.1155/2011/647987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
177 Weber JD, Gutmann DH. Deconvoluting mTOR biology. Cell Cycle 2012;11:236-48. [PMID: 22214661 DOI: 10.4161/cc.11.2.19022] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
178 Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998;19:348-355. [PMID: 9697695 DOI: 10.1038/1235] [Cited by in Crossref: 1055] [Cited by in F6Publishing: 1026] [Article Influence: 45.9] [Reference Citation Analysis]
179 Hamilton DL, Philp A, MacKenzie MG, Baar K. A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise. PLoS One 2010;5:e11624. [PMID: 20661274 DOI: 10.1371/journal.pone.0011624] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
180 Shi W, Zhang X, Pintilie M, Ma N, Miller N, Banerjee D, Tsao M, Mak T, Fyles A, Liu F. Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer 2003;104:195-203. [DOI: 10.1002/ijc.10909] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
181 Portelli S, Barr L, de Sá AGC, Pires DEV, Ascher DB. Distinguishing between PTEN clinical phenotypes through mutation analysis. Comput Struct Biotechnol J 2021;19:3097-109. [PMID: 34141133 DOI: 10.1016/j.csbj.2021.05.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Tilot AK, Frazier TW 2nd, Eng C. Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder. Neurotherapeutics 2015;12:609-19. [PMID: 25916396 DOI: 10.1007/s13311-015-0356-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
183 Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA. 1997;94:9052-9057. [PMID: 9256433 DOI: 10.1073/pnas.94.17.9052] [Cited by in Crossref: 526] [Cited by in F6Publishing: 526] [Article Influence: 21.9] [Reference Citation Analysis]
184 Stambolic V, Mak TW, Woodgett JR. Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene 1999;18:6094-103. [DOI: 10.1038/sj.onc.1203126] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 4.3] [Reference Citation Analysis]
185 Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Protein tyrosine phosphatases in the human genome. Cell. 2004;117:699-711. [PMID: 15186772 DOI: 10.1016/j.cell.2004.05.018] [Cited by in Crossref: 1331] [Cited by in F6Publishing: 1221] [Article Influence: 78.3] [Reference Citation Analysis]
186 Saavedra L, Catarino R, Heinz T, Heilmann I, Bezanilla M, Malhó R. Phosphatase and Tensin Homolog Is a Growth Repressor of Both Rhizoid and Gametophore Development in the Moss Physcomitrella patens. Plant Physiol 2015;169:2572-86. [PMID: 26463087 DOI: 10.1104/pp.15.01197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
187 Yu J, Koenig RJ. Thyroid-Specific PPARγ Deletion Is Benign in the Mouse. Endocrinology 2018;159:1463-8. [PMID: 29420754 DOI: 10.1210/en.2017-03163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
188 Fernández S, García-García M, Torres-Alemán I. Modulation by insulin-like growth factor I of the phosphatase PTEN in astrocytes. Biochim Biophys Acta 2008;1783:803-12. [PMID: 18062928 DOI: 10.1016/j.bbamcr.2007.10.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
189 Foulkes WD, Rosenblatt J, Chappuis PO. The contribution of inherited factors to the clinicopathological features and behavior of breast cancer. J Mammary Gland Biol Neoplasia 2001;6:453-65. [PMID: 12013534 DOI: 10.1023/a:1014791115760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
190 Kim B, Tabori U, Hawkins C. An update on the CNS manifestations of brain tumor polyposis syndromes. Acta Neuropathol 2020;139:703-15. [PMID: 31970492 DOI: 10.1007/s00401-020-02124-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
191 Rodolfo M, Daniotti M, Vallacchi V. Genetic progression of metastatic melanoma. Cancer Letters 2004;214:133-47. [DOI: 10.1016/j.canlet.2004.06.049] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
192 Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 2013;163C:114-21. [PMID: 23613428 DOI: 10.1002/ajmg.c.31364] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 10.9] [Reference Citation Analysis]
193 Wang X, Huang H, Young KH. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis. Aging (Albany NY) 2015;7:1032-49. [PMID: 26655726 DOI: 10.18632/aging.100855] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
194 Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, Eng C. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer. 2002;99:63-67. [PMID: 11948493 DOI: 10.1002/ijc.10294] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 6.4] [Reference Citation Analysis]
195 Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Investigation of germline PTEN, p53, p16INK4A/p14ARF, and CDK4 alterations in familial glioma. Am J Med Genet 2000;92:136-41. [DOI: 10.1002/(sici)1096-8628(20000515)92:2<136::aid-ajmg11>3.0.co;2-s] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
196 Landry CS, Waguespack SG, Perrier ND. Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review. Surg Clin North Am 2009;89:1069-89. [PMID: 19836485 DOI: 10.1016/j.suc.2009.06.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
197 Zhang Q, Claret FX. Phosphatases: the new brakes for cancer development? Enzyme Res. 2012;2012:659649. [PMID: 22121480 DOI: 10.1155/2012/659649] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
198 Ghosh AK, Grigorieva I, Steele R, Hoover RG, Ray RB. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene. 1999;235:85-91. [PMID: 10415336 DOI: 10.1016/s0378-1119(99)00206-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
199 Villeneuve H, Tremblay S, Galiatsatos P, Hamel N, Guertin L, Morency R, Tischkowitz M. Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? Fam Cancer 2011;10:691-4. [PMID: 21822720 DOI: 10.1007/s10689-011-9472-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
200 Robinson S, Cohen AR. Cowden Disease and Lhermitte-Duclos Disease: Characterization of a New Phakomatosis. Neurosurgery 2000;46:371-371. [DOI: 10.1097/00006123-200002000-00021] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
201 Jacobs C. A Review of the Role of Insulin-like Growth Factor 2 in Malignancy and its Potential as a Modifier of Radiation Sensitivity. Clinical Oncology 2008;20:345-52. [DOI: 10.1016/j.clon.2008.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
202 Wang X, Gjörloff-wingren A, Saxena M, Pathan N, Reed JC, Mustelin T. The Tumor Suppressor PTEN Regulates T Cell Survival and Antigen Receptor Signaling by Acting as a Phosphatidylinositol 3-Phosphatase. J Immunol 2000;164:1934-9. [DOI: 10.4049/jimmunol.164.4.1934] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
203 Krymskaya VP, Goncharova EA. PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle 2009;8:403-13. [PMID: 19177005 DOI: 10.4161/cc.8.3.7555] [Cited by in F6Publishing: 61] [Reference Citation Analysis]
204 Verhagen PC, van Duijn PW, Hermans KG, Looijenga LH, van Gurp RJ, Stoop H, van der Kwast TH, Trapman J. The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion. J Pathol 2006;208:699-707. [PMID: 16402365 DOI: 10.1002/path.1929] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
205 Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol 2000;20:9236-46. [PMID: 11094075 DOI: 10.1128/MCB.20.24.9236-9246.2000] [Cited by in Crossref: 74] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
206 Diallo-Krou E, Yu J, Colby LA, Inoki K, Wilkinson JE, Thomas DG, Giordano TJ, Koenig RJ. Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice. Endocrinology 2009;150:5181-90. [PMID: 19797117 DOI: 10.1210/en.2009-0701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
207 Igarashi A, Kato T, Sesaki H, Iijima M. Nuclear PTEN deficiency and heterozygous PTEN loss have distinct impacts on brain and lymph node size. Biochem Biophys Res Commun 2021;555:81-8. [PMID: 33813280 DOI: 10.1016/j.bbrc.2021.03.081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Davies EM, Sheffield DA, Tibarewal P, Fedele CG, Mitchell CA, Leslie NR. The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease. In: Balla T, Wymann M, York JD, editors. Phosphoinositides I: Enzymes of Synthesis and Degradation. Dordrecht: Springer Netherlands; 2012. pp. 281-336. [DOI: 10.1007/978-94-007-3012-0_8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
209 Tonin PN. Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 2000;18:281-6. [DOI: 10.1002/(sici)1098-2388(200006)18:4<281::aid-ssu2>3.0.co;2-q] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
210 Hansen GM, Justice MJ. Pten, a candidate tumor suppressor gene, maps to mouse chromosome 19. Mamm Genome 1998;9:88-90. [PMID: 9434957 DOI: 10.1007/s003359900690] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
211 Yoo LI, Chung DC, Yuan J. LKB1 — A master tumour suppressor of the small intestine and beyond. Nat Rev Cancer 2002;2:529-35. [DOI: 10.1038/nrc843] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 4.2] [Reference Citation Analysis]
212 Petersen I, Bockmühl U, Petersen S, Wolf G, Dietel M. Patterns of chromosomal imbalances in carcinomas of the respiratory tract. Adv Exp Med Biol 1998;451:9-16. [PMID: 10026843 DOI: 10.1007/978-1-4615-5357-1_2] [Reference Citation Analysis]
213 Tian XX, Zhang YG, Du J, Fang WG, Ng HK, Zheng J. Effects of cotransfection of antisense-EGFR and wild-type PTEN cDNA on human glioblastoma cells. Neuropathology. 2006;26:178-187. [PMID: 16771172 DOI: 10.1111/j.1440-1789.2006.00679.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
214 Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M. Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med. 2008;14:450-460. [PMID: 18775674 DOI: 10.1016/j.molmed.2008.08.003] [Cited by in Crossref: 257] [Cited by in F6Publishing: 241] [Article Influence: 19.8] [Reference Citation Analysis]
215 Kubica N, Jefferson LS, Kimball SR. Eukaryotic initiation factor 2B and its role in alterations in mRNA translation that occur under a number of pathophysiological and physiological conditions. Prog Nucleic Acid Res Mol Biol 2006;81:271-96. [PMID: 16891174 DOI: 10.1016/S0079-6603(06)81007-X] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
216 Zhang X, Yin B, Zhu F, Huang G, Li H. A PTEN translational isoform has PTEN-like activity. Chin J Cancer Res 2015;27:524-32. [PMID: 26543340 DOI: 10.3978/j.issn.1000-9604.2015.10.03] [Reference Citation Analysis]
217 Zolota VG, Tzelepi VN, Leotsinidis M, Zili PE, Panagopoulos ND, Dougenis D, Tsamandas AC, Scopa CD. Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma. J Surg Res 2010;164:256-65. [PMID: 19691991 DOI: 10.1016/j.jss.2009.03.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
218 Shi Y, Azab AN, Thompson MN, Greenberg ML. Inositol Phosphates and Phosphoinositides in Health and Disease. In: Majumder AL, Biswas BB, editors. Biology of Inositols and Phosphoinositides. Springer US; 2006. pp. 265-92. [DOI: 10.1007/0-387-27600-9_11] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
219 Boadi WY, Myles EL, Garcia AS. Phospho Tensin Homolog in Human and Lipid Peroxides in Peripheral Blood Mononuclear Cells Following Exposure to Flavonoids. J Am Coll Nutr 2020;39:135-46. [PMID: 31192773 DOI: 10.1080/07315724.2019.1616234] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
220 Eng C, Peacocke M. PTEN and inherited hamartoma-cancer syndromes. Nat Genet 1998;19:223-223. [DOI: 10.1038/897] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
221 Baens M, Wlodarska I, Corveleyn A, Hoornaert I, Hagemeijer A, Marynen P. A Physical, Transcript, and Deletion Map of Chromosome Region 12p12.3 Flanked byETV6andCDKN1B:Hypermethylation of theLRP6CpG Island in Two Leukemia Patients with Hemizygous del(12p). Genomics 1999;56:40-50. [DOI: 10.1006/geno.1998.5685] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
222 Cutillas PR, Khwaja A, Graupera M, Pearce W, Gharbi S, Waterfield M, Vanhaesebroeck B. Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. Proc Natl Acad Sci U S A 2006;103:8959-64. [PMID: 16751276 DOI: 10.1073/pnas.0602101103] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
223 Vasudevan KM, Garraway LA. AKT Signaling in Physiology and Disease. In: Rommel C, Vanhaesebroeck B, Vogt PK, editors. Phosphoinositide 3-kinase in Health and Disease. Berlin: Springer Berlin Heidelberg; 2011. pp. 105-33. [DOI: 10.1007/82_2010_66] [Cited by in Crossref: 32] [Cited by in F6Publishing: 61] [Article Influence: 2.9] [Reference Citation Analysis]
224 Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 1999;274:20693-20703. [PMID: 10400703 DOI: 10.1074/jbc.274.29.20693] [Cited by in Crossref: 254] [Cited by in F6Publishing: 260] [Article Influence: 11.5] [Reference Citation Analysis]
225 Suzuki A, Hamada K, Sasaki T, Mak TW, Nakano T. Role of PTEN/PI3K pathway in endothelial cells. Biochem Soc Trans. 2007;35:172-176. [PMID: 17371230 DOI: 10.1042/BST0350172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
226 Ito K, Kubokawa M, Harada N, Mibu R, Nawata H. p53 and PTEN/MMAC1 mutational analysis of the small-intestinal cancer. Dig Liver Dis. 2003;35:347-350. [PMID: 12846407 DOI: 10.1016/s1590-8658(03)00079-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
227 Keniry M, Parsons R. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene. 2008;27:5477-5485. [PMID: 18794882 DOI: 10.1038/onc.2008.248] [Cited by in Crossref: 250] [Cited by in F6Publishing: 234] [Article Influence: 19.2] [Reference Citation Analysis]
228 Lobo CJ, Mehan R, Murugasu E, Laitt RD. Tinnitus as the presenting symptom in a case of Lhermitte-Duclos disease. J Laryngol Otol 1999;113:464-5. [DOI: 10.1017/s0022215100144226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
229 He XC, Zhang J, Li L. Cellular and molecular regulation of hematopoietic and intestinal stem cell behavior. Ann NY Acad Sci. 2005;1049:28-38. [PMID: 15965105 DOI: 10.1196/annals.1334.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
230 Davies MP, Gibbs FE, Halliwell N, Joyce KA, Roebuck MM, Rossi ML, Salisbury J, Sibson DR, Tacconi L, Walker C. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. Br J Cancer 1999;79:1542-8. [PMID: 10188904 DOI: 10.1038/sj.bjc.6690246] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
231 Ciaccio C, Saletti V, D'Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet 2019;62:103596. [PMID: 30528446 DOI: 10.1016/j.ejmg.2018.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
232 Croushore JA, Blasiole B, Riddle RC, Thisse C, Thisse B, Canfield VA, Robertson GP, Cheng KC, Levenson R. Ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Dev Dyn 2005;234:911-21. [PMID: 16193492 DOI: 10.1002/dvdy.20576] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
233 Stolarov J, Chang K, Reiner A, Rodgers L, Hannon GJ, Wigler MH, Mittal V. Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc Natl Acad Sci U S A 2001;98:13043-8. [PMID: 11687610 DOI: 10.1073/pnas.221450598] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
234 Darvishian F, Hummer AJ, Thaler HT, Bhargava R, Linkov I, Asher M, Soslow RA. Serous Endometrial Cancers That Mimic Endometrioid Adenocarcinomas: A Clinicopathologic and Immunohistochemical Study of a Group of Problematic Cases. The American Journal of Surgical Pathology 2004;28:1568-78. [DOI: 10.1097/00000478-200412000-00004] [Cited by in Crossref: 108] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
235 Iwasa K, Hayashi S, Fujishiro T, Kanzaki N, Hashimoto S, Sakata S, Chinzei N, Nishiyama T, Kuroda R, Kurosaka M. PTEN regulates matrix synthesis in adult human chondrocytes under oxidative stress: MATRIX SYNTHESIS IN ADULT HUMAN CHONDROCYTES. J Orthop Res 2014;32:231-7. [DOI: 10.1002/jor.22506] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
236 Owonikoko TK, Khuri FR. Targeting the PI3K/AKT/mTOR pathway: biomarkers of success and tribulation. Am Soc Clin Oncol Educ Book. 2013;. [PMID: 23714559 DOI: 10.1200/EdBook_AM.2013.33.e395] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
237 Taketo MM, Takaku K. Gastro-intestinal tumorigenesis in Smad4 mutant mice. Cytokine & Growth Factor Reviews 2000;11:147-57. [DOI: 10.1016/s1359-6101(99)00038-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
238 Li JC, Samy ET, Grima J, Chung SS, Mruk D, Lee WM, Silvestrini B, Cheng CY. Rat testicular myotubularin, a protein tyrosine phosphatase expressed by Sertoli and germ cells, is a potential marker for studying cell-cell interactions in the rat testis. J Cell Physiol 2000;185:366-85. [DOI: 10.1002/1097-4652(200012)185:3<366::aid-jcp7>3.0.co;2-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
239 Spinelli L, Leslie NR. Assays to Measure PTEN Lipid Phosphatase Activity In Vitro from Purified Enzyme or Immunoprecipitates. Methods Mol Biol 2016;1447:95-105. [PMID: 27514802 DOI: 10.1007/978-1-4939-3746-2_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
240 Jønson L, Ahlborn LB, Steffensen AY, Djursby M, Ejlertsen B, Timshel S, Nielsen FC, Gerdes AM, Hansen TV. Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer. Breast Cancer Res Treat 2016;155:215-22. [PMID: 26740214 DOI: 10.1007/s10549-015-3674-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
241 Ming M, He YY. PTEN in DNA damage repair. Cancer Lett. 2012;319:125-129. [PMID: 22266095 DOI: 10.1016/j.canlet.2012.01.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 9.4] [Reference Citation Analysis]
242 Saito J, Kohn AD, Roth RA, Noguchi Y, Tatsumo I, Hirai A, Suzuki K, Kohn LD, Saji M, Ringel MD. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling. Thyroid 2001;11:339-51. [PMID: 11349832 DOI: 10.1089/10507250152039073] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
243 Gu T, Zhang Z, Wang J, Guo J, Shen WH, Yin Y. CREB is a novel nuclear target of PTEN phosphatase. Cancer Res 2011;71:2821-5. [PMID: 21385900 DOI: 10.1158/0008-5472.CAN-10-3399] [Cited by in Crossref: 88] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
244 Mester J, Eng C. Cowden syndrome: Recognizing and managing a not-so-rare hereditary cancer syndrome: Cowden Syndrome. J Surg Oncol 2015;111:125-30. [DOI: 10.1002/jso.23735] [Cited by in Crossref: 81] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
245 Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev 2004;18:1800-5. [PMID: 15289454 DOI: 10.1101/gad.1213804] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
246 Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 2005;36:768-76. [PMID: 16084946 DOI: 10.1016/j.humpath.2005.05.006] [Cited by in Crossref: 173] [Cited by in F6Publishing: 174] [Article Influence: 10.8] [Reference Citation Analysis]
247 He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, Dirisina R, Porter-Westpfahl KS, Hembree M, Johnson T, Wiedemann LM, Barrett TA, Hood L, Wu H, Li L. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007;39:189-98. [PMID: 17237784 DOI: 10.1038/ng1928] [Cited by in Crossref: 325] [Cited by in F6Publishing: 318] [Article Influence: 23.2] [Reference Citation Analysis]
248 Eng C. From bench to bedside... but when? Genome Res 1997;7:669-72. [PMID: 9253596 DOI: 10.1101/gr.7.7.669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
249 Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 2008;124:31-42. [DOI: 10.1007/s00439-008-0529-1] [Cited by in Crossref: 197] [Cited by in F6Publishing: 167] [Article Influence: 15.2] [Reference Citation Analysis]
250 Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387-390. [PMID: 10693755 DOI: 10.1016/s0092-8674(00)80674-1] [Cited by in Crossref: 807] [Cited by in F6Publishing: 350] [Article Influence: 38.4] [Reference Citation Analysis]
251 Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998;95:15587-91. [PMID: 9861013 DOI: 10.1073/pnas.95.26.15587] [Cited by in Crossref: 439] [Cited by in F6Publishing: 424] [Article Influence: 20.0] [Reference Citation Analysis]
252 Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003;3:559-70. [PMID: 12894244 DOI: 10.1038/nrc1145] [Cited by in Crossref: 196] [Cited by in F6Publishing: 164] [Article Influence: 10.9] [Reference Citation Analysis]
253 Gawron K, Łazarz-Bartyzel K, Potempa J, Chomyszyn-Gajewska M. Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet J Rare Dis 2016;11:9. [PMID: 26818898 DOI: 10.1186/s13023-016-0395-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
254 Malchoff CD, Malchoff DM. The Genetics of Hereditary Nonmedullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism 2002;87:2455-9. [DOI: 10.1210/jcem.87.6.8670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
255 Csolle MP, Ooms LM, Papa A, Mitchell CA. PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer. Int J Mol Sci 2020;21:E9189. [PMID: 33276499 DOI: 10.3390/ijms21239189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
256 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
257 Jornayvaz FR, Philippe J. Mucocutaneous papillomatous papules in Cowden’s syndrome. Clin Exp Dermatol 2008;33:151-3. [DOI: 10.1111/j.1365-2230.2007.02602.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
258 Zhang H, Wang Y, Xie JF, Liang X, Liu D, Yang P, Hsu H, Ray RB, Mountz JD. Regulation of tumor necrosis factor ?-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis & Rheumatism 2001;44:1555-67. [DOI: 10.1002/1529-0131(200107)44:7<1555::aid-art279>3.0.co;2-m] [Cited by in Crossref: 83] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
259 Morse CB, Garcia RL, Calhoun KE, Swisher EM. Premalignant alterations in breast and endometrium associated with a PTEN mutation in a woman with Cowden syndrome: implications for preventive care. Gynecol Oncol Rep 2015;12:13-6. [PMID: 26076150 DOI: 10.1016/j.gore.2015.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
260 Narla G, Sangodkar J, Ryder CB. The impact of phosphatases on proliferative and survival signaling in cancer. Cell Mol Life Sci 2018;75:2695-718. [PMID: 29725697 DOI: 10.1007/s00018-018-2826-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
261 Minobe K, Bando K, Fukino K, Soma S, Kasumi F, Sakamoto G, Furukawa K, Higuchi K, Onda M, Nakamura Y, Emi M. Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability. Cancer Letters 1999;144:9-16. [DOI: 10.1016/s0304-3835(99)00181-0] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
262 Owonikoko TK, Khuri FR. Targeting the PI3K/AKT/mTOR Pathway: Biomarkers of Success and Tribulation. American Society of Clinical Oncology Educational Book 2013. [DOI: 10.14694/edbook_am.2013.33.e395] [Cited by in Crossref: 10] [Article Influence: 1.3] [Reference Citation Analysis]
263 Namba H, Saenko V, Yamashita S. Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer. Arq Bras Endocrinol Metabol. 2007;51:843-851. [PMID: 17891249 DOI: 10.1590/s0004-27302007000500023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
264 Cidado J, Park BH. Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy. J Mammary Gland Biol Neoplasia 2012;17:205-16. [PMID: 22865098 DOI: 10.1007/s10911-012-9264-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
265 Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet 2016;9:83-92. [PMID: 27471403 DOI: 10.2147/TACG.S41947] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
266 Marsh DJ, Dahia PL, Caron S, Kum JB, Frayling IM, Tomlinson IP, Hughes KS, Eeles RA, Hodgson SV, Murday VA. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet. 1998;35:881-885. [PMID: 9832031 DOI: 10.1136/jmg.35.11.881] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
267 Thiffault I, Schwartz CE, Der Kaloustian V, Foulkes WD. Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am J Med Genet A 2004;130A:123-7. [PMID: 15372512 DOI: 10.1002/ajmg.a.30335] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
268 Boudeau J, Sapkota G, Alessi DR. LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett. 2003;546:159-165. [PMID: 12829253 DOI: 10.1016/s0014-5793(03)00642-2] [Cited by in Crossref: 127] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
269 Zhang Z, Hou SQ, He J, Gu T, Yin Y, Shen WH. PTEN regulates PLK1 and controls chromosomal stability during cell division. Cell Cycle 2016;15:2476-85. [PMID: 27398835 DOI: 10.1080/15384101.2016.1203493] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
270 Uppal S, Mistry D, Coatesworth AP. Cowden disease: a review: Cowden disease. International Journal of Clinical Practice 2007;61:645-52. [DOI: 10.1111/j.1742-1241.2006.00896.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
271 Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS, Lee DY. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett. 2001;172:83-91. [PMID: 11595133 DOI: 10.1016/s0304-3835(01)00632-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
272 Eng C. Cowden Syndrome. J Genet Counsel 1997;6:181-92. [DOI: 10.1023/a:1025664119494] [Cited by in Crossref: 81] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
273 Peiling Yang S, Ngeow J. Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocr Relat Cancer 2016;23:R577-95. [PMID: 27807061 DOI: 10.1530/ERC-16-0067] [Cited by in Crossref: 61] [Cited by in F6Publishing: 25] [Article Influence: 12.2] [Reference Citation Analysis]
274 Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, Xiong Y, Tseng LM, Li SH, Ding Z. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med. 2011;17:461-469. [PMID: 21399647 DOI: 10.1038/nm.2309] [Cited by in Crossref: 354] [Cited by in F6Publishing: 323] [Article Influence: 35.4] [Reference Citation Analysis]
275 Amer M, Mostafa FF, Attwa EM, Ibrahim S. Cowden's syndrome: a clinical, immunological, and histopathological study. Int J Dermatol 2011;50:516-21. [PMID: 21506964 DOI: 10.1111/j.1365-4632.2010.04669.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
276 Richards ML. Familial Syndromes Associated with Thyroid Cancer in the Era of Personalized Medicine. Thyroid 2010;20:707-13. [DOI: 10.1089/thy.2010.1641] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
277 Callahan R. The Role of Tumor Suppressor Genes in Breast Cancer Progression. In: Manni A, editor. Endocrinology of Breast Cancer. Totowa: Humana Press; 1999. pp. 119-32. [DOI: 10.1007/978-1-59259-699-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
278 Low SK, Chin YM, Ito H, Matsuo K, Tanikawa C, Matsuda K, Saito H, Sakurai-Yageta M, Nakaya N, Shimizu A, Nishizuka SS, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Takezaki T, Suzuki S, Naito M, Wakai K, Kamatani Y, Momozawa Y, Murakami Y, Inazawa J, Nakamura Y, Kubo M, Katagiri T, Miki Y. Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population. Sci Rep 2019;9:17332. [PMID: 31757997 DOI: 10.1038/s41598-019-53654-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
279 van den Berg H. Biology and therapy of malignant solid tumors in childhood. Cancer Chemother Biol Response Modif 2003;21:683-707. [PMID: 15338769 DOI: 10.1016/s0921-4410(03)21032-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
280 Chen CY, Chen J, He L, Stiles BL. PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne) 2018;9:338. [PMID: 30038596 DOI: 10.3389/fendo.2018.00338] [Cited by in Crossref: 109] [Cited by in F6Publishing: 106] [Article Influence: 36.3] [Reference Citation Analysis]
281 Hang Y, Zheng YC, Cao Y, Li QS, Sui YJ. Suppression of gastric cancer growth by adenovirus-mediated transfer of the PTEN gene. World J Gastroenterol 2005; 11(15): 2224-2229 [PMID: 15818730 DOI: 10.3748/wjg.v11.i15.2224] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
282 Mannan AU, Singh J, Lakshmikeshava R, Thota N, Singh S, Sowmya TS, Mishra A, Sinha A, Deshwal S, Soni MR, Chandrasekar A, Ramesh B, Ramamurthy B, Padhi S, Manek P, Ramalingam R, Kapoor S, Ghosh M, Sankaran S, Ghosh A, Veeramachaneni V, Ramamoorthy P, Hariharan R, Subramanian K. Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 2016;61:515-22. [PMID: 26911350 DOI: 10.1038/jhg.2016.4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
283 Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol. 1998;8:1169-1178. [PMID: 9799734 DOI: 10.1016/s0960-9822(07)00488-5] [Cited by in Crossref: 555] [Cited by in F6Publishing: 265] [Article Influence: 24.1] [Reference Citation Analysis]
284 Majumder PK, Sellers WR. Akt-regulated pathways in prostate cancer. Oncogene 2005;24:7465-74. [PMID: 16288293 DOI: 10.1038/sj.onc.1209096] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 15.1] [Reference Citation Analysis]
285 Hosoya Y, Gemma A, Seike M, Kurimoto F, Uematsu K, Hibino S, Yoshimura A, Shibuya M, Kudoh S. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Lung Cancer. 1999;25:87-93. [PMID: 10470842 DOI: 10.1016/s0169-5002(99)00052-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
286 Nakdimon I, Walser M, Fröhli E, Hajnal A. PTEN negatively regulates MAPK signaling during Caenorhabditis elegans vulval development. PLoS Genet 2012;8:e1002881. [PMID: 22916028 DOI: 10.1371/journal.pgen.1002881] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
287 Beguinot F. PTEN targeting: the search for novel insulin sensitisers provides new insight into obesity research. Diabetologia 2007;50:247-9. [DOI: 10.1007/s00125-006-0547-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
288 Machado RA, Paranaíba LMR, Martins L, Melo-filho MR, de Souza TT, Picciani BLS, Silva-junior GO, Cantisano MH, Rocha BA, Pires FR, Coletta RD. Variable expressivity and novel PTEN mutations in Cowden syndrome. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019;127:55-61. [DOI: 10.1016/j.oooo.2018.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Shiraishi T, Tabuchi K. Genetic alterations of human brain tumors as molecular prognostic factors. Neuropathology 2003;23:95-108. [DOI: 10.1046/j.1440-1789.2003.00477.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
290 Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA. 1999;96:1563-1568. [PMID: 9990064 DOI: 10.1073/pnas.96.4.1563] [Cited by in Crossref: 708] [Cited by in F6Publishing: 654] [Article Influence: 32.2] [Reference Citation Analysis]
291 van der Velden JJAJ, Vreeburg M, Smeets EEJ, Schrander-stumpel CTRM, van Steensel MAM. Skin abnormalities in individuals with macrocephaly: Cowden disease from a dermatologist's point of view. International Journal of Dermatology 2008;47:45-8. [DOI: 10.1111/j.1365-4632.2008.03960.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
292 Rasool S, Rasool V, Naqvi T, Ganai BA, Shah BA. Genetic unraveling of colorectal cancer. Tumour Biol. 2014;35:5067-5082. [PMID: 24573608 DOI: 10.1007/s13277-014-1713-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
293 Rademaker J, Kim YJ, Leibecke T, Raman SS, Voit C. Cowden disease: CT findings in three patients. Abdom Imaging 2005;30:204-7. [DOI: 10.1007/s00261-004-0250-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
294 Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG. Modulation of inflammation by autophagy: Consequences for human disease. Autophagy. 2016;12:245-260. [PMID: 26222012 DOI: 10.1080/15548627.2015.1071759] [Cited by in Crossref: 181] [Cited by in F6Publishing: 182] [Article Influence: 30.2] [Reference Citation Analysis]
295 Evans HS, Lewis CM, Robinson D, Bell CM, Møller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 2001;84:435-40. [PMID: 11161413 DOI: 10.1054/bjoc.2000.1603] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
296 Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, Zhao P, Dykema K, Zhang R, Cao B, Yang XJ, Furge K, Williams BO, Teh BT. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One 2008;3:e3581. [PMID: 18974783 DOI: 10.1371/journal.pone.0003581] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 7.9] [Reference Citation Analysis]
297 Celebi JT, Shendrik I, Silvers DN, Peacocke M. Identification of PTEN mutations in metastatic melanoma specimens. J Med Genet. 2000;37:653-657. [PMID: 10978354 DOI: 10.1136/jmg.37.9.653] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
298 He T, Zhang X, Hao J, Ding S. Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor. Front Physiol 2021;12:684529. [PMID: 34140896 DOI: 10.3389/fphys.2021.684529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Luzón-Toro B, Fernández RM, Villalba-Benito L, Torroglosa A, Antiñolo G, Borrego S. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis. Genes (Basel) 2019;10:E913. [PMID: 31717449 DOI: 10.3390/genes10110913] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
300 Gorbenko O, Stambolic V. PTEN at 18: Still Growing. Methods Mol Biol 2016;1388:13-9. [PMID: 27033067 DOI: 10.1007/978-1-4939-3299-3_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
301 Hirai Y, Tanaka N, Furuta R, Kawaguchi T, Sakamoto M, Shirahama S, Noda T. Somatic Mutations of the PTEN/MMAC1 Gene Associated with Frequent Chromosomal Loss Detected Using Comparative Genomic Hybridization in Endometrial Cancer. Gynecologic Oncology 2001;83:81-8. [DOI: 10.1006/gyno.2001.6320] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
302 Lachlan KL. Cowden syndrome and the PTEN hamartoma tumor syndrome: how to define rare genetic syndromes. J Natl Cancer Inst 2013;105:1595-7. [PMID: 24136892 DOI: 10.1093/jnci/djt290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
303 Lazzereschi D, Palmirotta R, Ranieri A, Ottini L, Verì MC, Cama A, Cetta F, Nardi F, Colletta G, Mariani-Costantini R. Microsatellite instability in thyroid tumours and tumour-like lesions. Br J Cancer 1999;79:340-5. [PMID: 9888478 DOI: 10.1038/sj.bjc.6690054] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
304 Meric-Bernstam F, Gonzalez-Angulo AM. Targeting the mTOR signaling network for cancer therapy. J Clin Oncol. 2009;27:2278-2287. [PMID: 19332717 DOI: 10.1200/jco.2008.20.0766] [Cited by in Crossref: 453] [Cited by in F6Publishing: 250] [Article Influence: 37.8] [Reference Citation Analysis]
305 Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T. Allelic imbalance and mutations of thePTEN gene in ovarian cancer. Int J Cancer 2000;85:160-5. [DOI: 10.1002/(sici)1097-0215(20000115)85:2<160::aid-ijc2>3.0.co;2-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
306 Van Gele M, Leonard JH, Van Roy N, Cook AL, De Paepe A, Speleman F. Frequent allelic loss at 10q23 but low incidence ofPTEN mutations in merkel cell carcinoma. Int J Cancer 2001;92:409-13. [DOI: 10.1002/ijc.1209] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
307 Feng J, Dang Y, Zhang W, Zhao X, Zhang C, Hou Z, Jin Y, McNutt MA, Marks AR, Yin Y. PTEN arginine methylation by PRMT6 suppresses PI3K-AKT signaling and modulates pre-mRNA splicing. Proc Natl Acad Sci U S A 2019;116:6868-77. [PMID: 30886105 DOI: 10.1073/pnas.1811028116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
308 Woodford-Richens K, Bevan S, Churchman M, Dowling B, Jones D, Norbury CG, Hodgson SV, Desai D, Neale K, Phillips RK, Young J, Leggett B, Dunlop M, Rozen P, Eng C, Markie D, Rodriguez-Bigas MA, Sheridan E, Iwama T, Eccles D, Smith GT, Kim JC, Kim KM, Sampson JR, Evans G, Tejpar S, Bodmer WF, Tomlinson IP, Houlston RS. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut. 2000;46:656-660. [PMID: 10764709 DOI: 10.1136/gut.46.5.656] [Cited by in Crossref: 87] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
309 Zhou XP, Hampel H, Roggenbuck J, Saba N, Prior TW, Eng C. A 39-bp deletion polymorphism in PTEN in African American individuals: implications for molecular diagnostic testing. J Mol Diagn 2002;4:114-7. [PMID: 11986403 DOI: 10.1016/S1525-1578(10)60690-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
310 Huang PY, Balmain A. Modeling cutaneous squamous carcinoma development in the mouse. Cold Spring Harb Perspect Med 2014;4:a013623. [PMID: 25183851 DOI: 10.1101/cshperspect.a013623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
311 Wang ZJ, Taylor F, Churchman M, Norbury G, Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 1998;153:363-6. [PMID: 9708796 DOI: 10.1016/S0002-9440(10)65579-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
312 Nagy R, Ringel MD. Genetic predisposition for nonmedullary thyroid cancer. Horm Cancer 2015;6:13-20. [PMID: 25338077 DOI: 10.1007/s12672-014-0205-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
313 Kalli AC, Devaney I, Sansom MS. Interactions of phosphatase and tensin homologue (PTEN) proteins with phosphatidylinositol phosphates: insights from molecular dynamics simulations of PTEN and voltage sensitive phosphatase. Biochemistry 2014;53:1724-32. [PMID: 24588644 DOI: 10.1021/bi5000299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
314 Inoki K, Ouyang H, Li Y, Guan KL. Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev. 2005;69:79-100. [PMID: 15755954 DOI: 10.1128/mmbr.69.1.79-100.2005] [Cited by in Crossref: 239] [Cited by in F6Publishing: 128] [Article Influence: 14.9] [Reference Citation Analysis]
315 Rustad CF, Bjørnslett M, Heimdal KR, Mæhle L, Apold J, Møller P. Germline PTEN mutations are rare and highly penetrant. Hered Cancer Clin Pract 2006;4:177-85. [PMID: 20223021 DOI: 10.1186/1897-4287-4-4-177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
316 Simpson L, Li J, Liaw D, Hennessy I, Oliner J, Christians F, Parsons R. PTEN expression causes feedback upregulation of insulin receptor substrate 2. Mol Cell Biol 2001;21:3947-58. [PMID: 11359902 DOI: 10.1128/MCB.21.12.3947-3958.2001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
317 Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol. 2003;84:166-172. [PMID: 14598361 DOI: 10.1002/jso.10302] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
318 Hassan B, Akcakanat A, Holder AM, Meric-Bernstam F. Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am 2013;22:641-64. [PMID: 24012393 DOI: 10.1016/j.soc.2013.06.008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 12.0] [Reference Citation Analysis]
319 Coupier I, Cousin P, Hughes D, Legoix-né P, Trehin A, Sinilnikova OM, Stoppa-lyonnet D. BAP1 and Breast Cancer Risk. Familial Cancer 2005;4:273-7. [DOI: 10.1007/s10689-005-2833-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
320 Wu Y, Huang D, Zhang H, Weng X, Wang H, Zhou Q, Wu Y, Shen Y, Sun B, Hu Z. The frequency of PTEN germline mutations in Chinese breast cancer patients: The PTEN gene may not be closely associated with breast cancer in the Chinese population. Gene 2020;744:144630. [PMID: 32234455 DOI: 10.1016/j.gene.2020.144630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 . FEATURES. Asia-Pacific Biotech News 2016;20:12-32. [DOI: 10.1142/s0219030316000252] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Bishop D. BRCA1 and BRCA2 and breast cancer incidence: A review. Annals of Oncology 1999;10:S113-20. [DOI: 10.1093/annonc/10.suppl_6.s113] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
323 Teitell MA, Pandolfi PP. Lymphoid Malignancies. In: Holland EC, editor. Mouse Models of Human Cancer. Hoboken: John Wiley & Sons, Inc.; 2004. [DOI: 10.1002/0471675067.mmc014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
324 Mita MM, Mita A, Rowinsky EK. Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer. Clinical Breast Cancer 2003;4:126-37. [DOI: 10.3816/cbc.2003.n.018] [Cited by in Crossref: 91] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
325 Smith IN, Thacker S, Seyfi M, Cheng F, Eng C. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer. Am J Hum Genet 2019;104:861-78. [PMID: 31006514 DOI: 10.1016/j.ajhg.2019.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
326 Haas NB, Nathanson KL. Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis 2014;21:81-90. [PMID: 24359990 DOI: 10.1053/j.ackd.2013.10.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 11.3] [Reference Citation Analysis]
327 Tait IS, Li Y, Lu J. PTEN, Longevity and Age-Related Diseases. Biomedicines 2013;1:17-48. [PMID: 28548055 DOI: 10.3390/biomedicines1010017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
328 Hendriks YM, Verhallen JT, van der Smagt JJ, Kant SG, Hilhorst Y, Hoefsloot L, Hansson KB, van der Straaten PJ, Boutkan H, Breuning MH, Vasen HF, Bröcker-Vriends AH. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer 2003;2:79-85. [PMID: 14574156 DOI: 10.1023/a:1025713815924] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
329 Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. Biochem Biophys Res Commun. 2002;292:422-426. [PMID: 11906179 DOI: 10.1006/bbrc.2002.6662] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
330 Soysal Y, Tate G, Polat C, Polat N, Aktepe F, Sıvacı Y, Imirzalıoglu N. Analysis of PTEN Gene Mutations in a Turkish Patient with Cowden Syndrome. Genetic Testing and Molecular Biomarkers 2009;13:547-51. [DOI: 10.1089/gtmb.2009.0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
331 Cohen S, Hyer W, Mas E, Auth M, Attard TM, Spalinger J, Latchford A, Durno C. Management of Juvenile Polyposis Syndrome in Children and Adolescents: A Position Paper From the ESPGHAN Polyposis Working Group. J Pediatr Gastroenterol Nutr 2019;68:453-62. [PMID: 30585890 DOI: 10.1097/MPG.0000000000002246] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 23.0] [Reference Citation Analysis]
332 Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, Gunter SA, Christian SL, Collins S, Adams C, Rivière JB, St-Onge J, Ojemann JG, Shendure J, Hevner RF, Dobyns WB. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 2015;138:1613-28. [PMID: 25722288 DOI: 10.1093/brain/awv045] [Cited by in Crossref: 183] [Cited by in F6Publishing: 159] [Article Influence: 30.5] [Reference Citation Analysis]
333 Hoyal CR, Kammerer S, Roth RB, Reneland R, Marnellos G, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ebner F, Rehbock J, Nelson MR, Braun A. Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases. J Carcinog 2005;4:13. [PMID: 16109180 DOI: 10.1186/1477-3163-4-13] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
334 Tanaka M, Koul D, Davies MA, Liebert M, Steck PA, Grossman HB. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Oncogene 2000;19:5406-12. [PMID: 11103942 DOI: 10.1038/sj.onc.1203918] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
335 Jaini R, Loya MG, King AT, Thacker S, Sarn NB, Yu Q, Stark GR, Eng C. Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice. Hum Mol Genet 2020;29:2353-64. [PMID: 32588888 DOI: 10.1093/hmg/ddaa118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
336 Martinez R, Schackert HK, von Kannen S, Lichter P, Joos S, Schackert G. Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval. Brain Pathol 2003;13:598-607. [PMID: 14655763 DOI: 10.1111/j.1750-3639.2003.tb00488.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
337 Singh G, Akcakanat A, Sharma C, Luyimbazi D, Naff KA, Meric-Bernstam F. The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivo. Nutr Cancer 2011;63:264-71. [PMID: 21294052 DOI: 10.1080/01635581.2011.523504] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
338 Aguissa-touré A, Li G. Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 2012;69:1475-91. [DOI: 10.1007/s00018-011-0878-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
339 Zhu L, T.y. Loo W, Louis WC. PTEN and VEGF: Possible predictors for sentinel lymph node micro-metastasis in breast cancer. Biomedicine & Pharmacotherapy 2007;61:558-61. [DOI: 10.1016/j.biopha.2007.08.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
340 Higgins SE, Barletta JA. Applications of Immunohistochemistry to Endocrine Pathology. Adv Anat Pathol 2018;25:413-29. [PMID: 30157042 DOI: 10.1097/PAP.0000000000000209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
341 Rubin MA, Gerstein A, Reid K, Bostwick DG, Cheng L, Parsons R, Papadopoulos N. 10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer. Hum Pathol. 2000;31:504-508. [PMID: 10821499 DOI: 10.1053/hp.2000.6713] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
342 Luukko K, Ylikorkala A, Tiainen M, Mäkelä TP. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mechanisms of Development 1999;83:187-90. [DOI: 10.1016/s0925-4773(99)00050-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
343 Jang K, Song YS, Jang S, Min K, Na W, Jang SM, Jun YJ, Lee KH, Choi D, Paik SS. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology 2010;56:229-39. [DOI: 10.1111/j.1365-2559.2009.03468.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
344 Zou H, Ding Y, Wang K, Xiong E, Peng W, Du F, Zhang Z, Liu J, Gong A. MicroRNA-29A/PTEN pathway modulates neurite outgrowth in PC12 cells. Neuroscience 2015;291:289-300. [PMID: 25665754 DOI: 10.1016/j.neuroscience.2015.01.055] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
345 Li H, Zhang P, Zhang Q, Li C, Zou W, Chang Z, Cui CP, Zhang L. WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice. J Biol Chem 2018;293:8886-99. [PMID: 29685889 DOI: 10.1074/jbc.RA117.001060] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
346 Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A 2001;98:11563-8. [PMID: 11553783 DOI: 10.1073/pnas.201167798] [Cited by in Crossref: 236] [Cited by in F6Publishing: 208] [Article Influence: 11.8] [Reference Citation Analysis]
347 Ghevariya V, Singhal S, Anand S. The skin: a mirror to the gut. Int J Colorectal Dis 2013;28:889-913. [PMID: 23329214 DOI: 10.1007/s00384-012-1637-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
348 Hemel D, Domchek SM. Breast cancer predisposition syndromes. Hematol Oncol Clin North Am 2010;24:799-814. [PMID: 20816575 DOI: 10.1016/j.hoc.2010.06.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
349 Pópulo H, Lopes JM, Soares P. The mTOR Signalling Pathway in Human Cancer. Int J Mol Sci. 2012;13:1886-1918. [PMID: 22408430 DOI: 10.3390/ijms13021886] [Cited by in Crossref: 424] [Cited by in F6Publishing: 403] [Article Influence: 47.1] [Reference Citation Analysis]
350 Hsieh SC, Chen NT, Lo SH. Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation. Mol Carcinog 2009;48:545-52. [PMID: 18973188 DOI: 10.1002/mc.20491] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
351 Hoffenberg EJ, Sauaia A, Maltzman T, Knoll K, Ahnen DJ. Symptomatic colonic polyps in childhood: not so benign. J Pediatr Gastroenterol Nutr 1999;28:175-81. [PMID: 9932851 DOI: 10.1097/00005176-199902000-00016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
352 Chi H, Tiller GE, Dasouki MJ, Romano PR, Wang J, O'keefe RJ, Puzas J, Rosier RN, Reynolds PR. Multiple Inositol Polyphosphate Phosphatase: Evolution as a Distinct Group within the Histidine Phosphatase Family and Chromosomal Localization of the Human and Mouse Genes to Chromosomes 10q23 and 19. Genomics 1999;56:324-36. [DOI: 10.1006/geno.1998.5736] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
353 Puc J, Placha G, Wocial B, Podsypanina K, Parsons R, Gaciong Z. Analysis of PTEN mutation in non-familial pheochromocytoma. Ann N Y Acad Sci 2006;1073:317-31. [PMID: 17102102 DOI: 10.1196/annals.1353.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
354 Diamond TM, Sutphen R, Tabano M, Fiorica J. Inherited susceptibility to breast and ovarian cancer: . Current Opinion in Obstetrics and Gynaecology 1998;10:3-8. [DOI: 10.1097/00001703-199802000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
355 Christensen R, de la Torre-Ubieta L, Bonni A, Colón-Ramos DA. A conserved PTEN/FOXO pathway regulates neuronal morphology during C. elegans development. Development 2011;138:5257-67. [PMID: 22069193 DOI: 10.1242/dev.069062] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
356 Moley JF, Lairmore TC, Phay JE. Hereditary endocrinopathies. Current Problems in Surgery 1999;36:653-762. [DOI: 10.1016/s0011-3840(99)80001-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
357 Dahia P. Descobrindo Genes no Século XXI: Enfoque na Área de Onco-Endocrinologia. Arq Bras Endocrinol Metab 2002;46:341-50. [DOI: 10.1590/s0004-27302002000400005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
358 Mikhail S, Zeidan A. Stem cells in gastrointestinal cancers: The road less travelled. World J Stem Cells 2014; 6(5): 606-613 [PMID: 25426257 DOI: 10.4252/wjsc.v6.i5.606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
359 Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005;94:29-86. [PMID: 16095999 DOI: 10.1016/s0065-230x(05)94002-5] [Cited by in Crossref: 526] [Cited by in F6Publishing: 285] [Article Influence: 32.9] [Reference Citation Analysis]
360 Conde-Perez A, Larue L. PTEN and melanomagenesis. Future Oncol 2012;8:1109-20. [PMID: 23030486 DOI: 10.2217/fon.12.106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
361 Celentano A, Adamo D, Leuci S, Mignogna MD. Oral manifestations of phosphatase and tensin homolog hamartoma tumor syndrome: a report of three cases. J Am Dent Assoc 2014;145:950-4. [PMID: 25170002 DOI: 10.14219/jada.2014.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
362 Hopkins BD, Parsons RE. Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy. Clin Cancer Res 2014;20:5379-83. [PMID: 25361917 DOI: 10.1158/1078-0432.CCR-13-2661] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
363 Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007;44:579-85. [PMID: 17526800 DOI: 10.1136/jmg.2007.049981] [Cited by in Crossref: 123] [Cited by in F6Publishing: 93] [Article Influence: 8.8] [Reference Citation Analysis]
364 Mizuno S, Takeichi T, Sato J, Nakamura M, Goto H, Sugiura K, Akiyama M. Multiple keratotic papules and plaques on the trunk in Cowden's disease with MALT lymphoma. J Dermatol 2018;45:238-40. [PMID: 28391632 DOI: 10.1111/1346-8138.13851] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
365 Guldberg P, Straten PT, Ahrenkiel V, Seremet T, Kirkin AF, Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 1999;18:1777-80. [DOI: 10.1038/sj.onc.1202486] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 4.0] [Reference Citation Analysis]
366 Biswal BN, Das SN, Das BK, Rath R. Alteration of cellular metabolism in cancer cells and its therapeutic prospects. J Oral Maxillofac Pathol 2017;21:244-51. [PMID: 28932034 DOI: 10.4103/jomfp.JOMFP_60_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
367 Heaney RM, Farrell M, Stokes M, Gorey T, Murray D. Cowden Syndrome: Serendipitous Diagnosis in Patients with Significant Breast Disease. Case Series and Literature Review. Breast J 2017;23:90-4. [PMID: 27886412 DOI: 10.1111/tbj.12691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
368 Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017;173:1017-37. [PMID: 28168833 DOI: 10.1002/ajmg.a.38142] [Cited by in Crossref: 101] [Cited by in F6Publishing: 73] [Article Influence: 25.3] [Reference Citation Analysis]
369 Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am 2012;96:329-49. [PMID: 22443979 DOI: 10.1016/j.mcna.2012.02.002] [Cited by in Crossref: 100] [Cited by in F6Publishing: 78] [Article Influence: 11.1] [Reference Citation Analysis]
370 Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, Lamon C, Hutter P, Antonarakis SE. The TPTE gene family: cellular expression, subcellular localization and alternative splicing. Gene 2003;323:189-99. [DOI: 10.1016/j.gene.2003.09.038] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
371 Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460. [PMID: 20018966 DOI: 10.1056/nejmra0804588] [Cited by in Crossref: 1098] [Cited by in F6Publishing: 675] [Article Influence: 99.8] [Reference Citation Analysis]
372 Matthews MA, Adler BH, Arnold MA, Kumar S, Carvalho R, Besner GE. Diffuse intestinal ganglioneuromatosis in a child. J Pediatr Surg 2013;48:1129-33. [PMID: 23701793 DOI: 10.1016/j.jpedsurg.2013.03.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
373 Bardeesy N, Wong KK, DePinho RA, Chin L. Animal models of melanoma: recent advances and future prospects. Adv Cancer Res 2000;79:123-56. [PMID: 10818679 DOI: 10.1016/s0065-230x(00)79004-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
374 Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, Qiao R, Liu X, Wu H. Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis. Mol Cell Biol 2002;22:3842-51. [PMID: 11997518 DOI: 10.1128/MCB.22.11.3842-3851.2002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
375 Yeh KT, Chang JG, Chen YJ, Chen ST, Yu SY, Shih MC, Perng LI, Wang JC, Tsai M, Chang CP. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Cancer Invest. 2000;18:123-129. [PMID: 10705874 DOI: 10.3109/07357900009038243] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
376 Karoui M, Tresallet C, Julie C, Zimmermann U, Staroz F, Brams A, Muti C, Boulard C, Robreau AM, Puy H. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. Br J Cancer. 2004;90:1230-1234. [PMID: 15026806 DOI: 10.1038/sj.bjc.6601687] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
377 Mohiuddin I, Cao X, Ozvaran MK, Zumstein L, Chada S, Smythe WR. Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation. Annals of Surgical Oncology 2002;9:310-6. [DOI: 10.1007/bf02573071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
378 Li L, He F, Litofsky NS, Recht LD, Ross AH. Profiling of genes expressed by PTEN haploinsufficient neural precursor cells. Mol Cell Neurosci 2003;24:1051-61. [PMID: 14697668 DOI: 10.1016/j.mcn.2003.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
379 Lee JS, Kim HS, Kim YB, Lee MC, Park CS, Min KW. Reduced PTEN Expression Is Associated With Poor Outcome and Angiogenesis in Invasive Ductal Carcinoma of the Breast: . Applied Immunohistochemistry & Molecular Morphology 2004;12:205-10. [DOI: 10.1097/00129039-200409000-00004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
380 Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells: PI3K/Akt Survival Pathway Inhibition in Prostate Cancer Cells. Prostate 2004;58:259-68. [DOI: 10.1002/pros.10332] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
381 Horvath A, Stratakis CA. Carney complex and lentiginosis. Pigment Cell Melanoma Res 2009;22:580-7. [PMID: 19650827 DOI: 10.1111/j.1755-148X.2009.00613.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
382 Jiang B, Liu L. Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis. Elsevier; 2009. pp. 19-65. [DOI: 10.1016/s0065-230x(09)02002-8] [Cited by in Crossref: 308] [Cited by in F6Publishing: 199] [Article Influence: 25.7] [Reference Citation Analysis]
383 Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. Biochem J. 2000;346 Pt 3:827-833. [PMID: 10698713 DOI: 10.1042/bj3460827] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
384 Smith WM, Van Orsouw NJ, Fox EA, Kolodner RD, Vijg J, Eng C. Accurate, High-Throughput "Snapshot" Detection of hMLHl Mutations by Two-Dimensional DNA Electrophoresis. Genetic Testing 1998;2:43-53. [DOI: 10.1089/gte.1998.2.43] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
385 Ismail A, Ning K, Al-hayani A, Sharrack B, Azzouz M. PTEN: A molecular target for neurodegenerative disorders. Translational Neuroscience 2012;3. [DOI: 10.2478/s13380-012-0018-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Friedl W, Kruse R, Uhlhaas S, Stolte M, Schartmann B, Keller KM, Jungck M, Stern M, Loff S, Back W, Propping P, Jenne DE. Frequent 4-bp deletion in exon 9 of theSMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosom Cancer 1999;25:403-6. [DOI: 10.1002/(sici)1098-2264(199908)25:4<403::aid-gcc15>3.0.co;2-p] [Cited by in Crossref: 68] [Article Influence: 3.1] [Reference Citation Analysis]
387 Staiano L, De Leo MG, Persico M, De Matteis MA. Mendelian disorders of PI metabolizing enzymes. Biochim Biophys Acta 2015;1851:867-81. [PMID: 25510381 DOI: 10.1016/j.bbalip.2014.12.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
388 Frisk T, Foukakis T, Dwight T, Lundberg J, Höög A, Wallin G, Eng C, Zedenius J, Larsson C. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer 2002;35:74-80. [PMID: 12203792 DOI: 10.1002/gcc.10098] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
389 Mizuguchi M. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex. Congenit Anom (Kyoto) 2007;47:2-8. [PMID: 17300684 DOI: 10.1111/j.1741-4520.2006.00134.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
390 Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C, Pacini F. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab 2008;93:3950-7. [PMID: 18664542 DOI: 10.1210/jc.2008-0372] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
391 Yaginuma Y, Yamashita T, Ishiya T, Morizaki A, Katoh Y, Takahashi T, Hayashi H, Ishikawa M. Abnormal structure and expression ofPTEN/MMAC1 gene in human uterine cancers. Mol Carcinog 2000;27:110-6. [DOI: 10.1002/(sici)1098-2744(200002)27:2<110::aid-mc6>3.0.co;2-e] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
392 Banno K, Nogami Y, Kisu I, Yanokura M, Umene K, Masuda K, Kobayashi Y, Yamagami W, Susumu N, Aoki D. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer. Int J Mol Sci 2013;14:12123-37. [PMID: 23743825 DOI: 10.3390/ijms140612123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
393 Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C. Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry. 2015;20:1132-1138. [PMID: 25288137 DOI: 10.1038/mp.2014.125] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
394 Tantravahi SK, Schumacher J, Burt RW, Kelley TW, Deininger MWN. Systemic mastocytosis in a patient with Cowden syndrome. Am J Hematol 2014;89:1154-1154. [DOI: 10.1002/ajh.23815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
395 Nishizawa A, Satoh T, Watanabe R, Takayama K, Nakano H, Sawamura D, Yokozeki H. Cowden syndrome: a novel mutation and overlooked glycogenic acanthosis in gingiva. British Journal of Dermatology 2009;160:1116-8. [DOI: 10.1111/j.1365-2133.2009.09072.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
396 Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S, Cognetti F, Ciuffreda L. PTEN: Multiple Functions in Human Malignant Tumors. Front Oncol 2015;5:24. [PMID: 25763354 DOI: 10.3389/fonc.2015.00024] [Cited by in Crossref: 222] [Cited by in F6Publishing: 233] [Article Influence: 37.0] [Reference Citation Analysis]
397 Abbas A, Padmanabhan R, Romigh T, Eng C. PTEN modulates gene transcription by redistributing genome-wide RNA polymerase II occupancy. Hum Mol Genet 2019;28:2826-34. [PMID: 31127935 DOI: 10.1093/hmg/ddz112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
398 Black D, Bogomolniy F, Robson ME, Offit K, Barakat RR, Boyd J. Evaluation of germline PTEN mutations in endometrial cancer patients. Gynecol Oncol 2005;96:21-4. [PMID: 15589575 DOI: 10.1016/j.ygyno.2004.09.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
399 Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008;27:5387-97. [PMID: 18794875 DOI: 10.1038/onc.2008.237] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
400 Ijuin T. Phosphoinositide phosphatases in cancer cell dynamics-Beyond PI3K and PTEN. Semin Cancer Biol 2019;59:50-65. [PMID: 30922959 DOI: 10.1016/j.semcancer.2019.03.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
401 Zhang C, Tada M, Kobayashi H, Nozaki M, Moriuchi T, Abe H. Detection of PTEN nonsense mutation and ψPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay. Oncogene 2000;19:4346-53. [DOI: 10.1038/sj.onc.1203795] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
402 Lopez C, Abuel-Haija M, Pena L, Coppola D. Novel Germline PTEN Mutation Associated with Cowden Syndrome and Osteosarcoma. Cancer Genomics Proteomics 2018;15:115-20. [PMID: 29496690 DOI: 10.21873/cgp.20069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
403 Liu YL, Castleberry RP, Emanuel PD. PTEN deficiency is a common defect in juvenile myelomonocytic leukemia. Leuk Res 2009;33:671-7. [PMID: 19010541 DOI: 10.1016/j.leukres.2008.09.036] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
404 Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, Eng C. ATP modulates PTEN subcellular localization in multiple cancer cell lines. Human Molecular Genetics 2008;17:2877-85. [DOI: 10.1093/hmg/ddn185] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
405 Rossi DJ, Ylikorkala A, Korsisaari N, Salovaara R, Luukko K, Launonen V, Henkemeyer M, Ristimaki A, Aaltonen LA, Makela TP. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci U S A. 2002;99:12327-12332. [PMID: 12218179 DOI: 10.1073/pnas.192301399] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 4.4] [Reference Citation Analysis]
406 Mighell TL, Thacker S, Fombonne E, Eng C, O'Roak BJ. An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships. Am J Hum Genet 2020;106:818-29. [PMID: 32442409 DOI: 10.1016/j.ajhg.2020.04.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
407 Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, Jalaludin B, Segelov E. PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene. 2004;23:617-628. [PMID: 14724591 DOI: 10.1038/sj.onc.1207059] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 5.9] [Reference Citation Analysis]
408 Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T. Allelic imbalance and mutations of thePTEN gene in ovarian cancer. Int J Cancer 2000;85:160-5. [DOI: 10.1002/(sici)1097-0215(20000115)85:2<160::aid-ijc2>3.0.co;2-5] [Cited by in Crossref: 58] [Article Influence: 2.8] [Reference Citation Analysis]
409 Vantomme N, Van Calenbergh F, Goffin J, Sciot R, Demaerel P, Plets C. Lhermitte–Duclos disease is a clinical manifestation of Cowden’s syndrome. Surgical Neurology 2001;56:201-4. [DOI: 10.1016/s0090-3019(01)00552-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
410 Karan D, Lin MF, Johansson SL, Batra SK. Current status of the molecular genetics of human prostatic adenocarcinomas. Int J Cancer 2003;103:285-93. [PMID: 12471610 DOI: 10.1002/ijc.10813] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
411 Yoganathan T, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J. Integrin-linked kinase (ILK): a “hot” therapeutic target. Biochemical Pharmacology 2000;60:1115-9. [DOI: 10.1016/s0006-2952(00)00444-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
412 Gimm O. Thyroid cancer. Cancer Letters 2001;163:143-56. [DOI: 10.1016/s0304-3835(00)00697-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
413 Schneider KA. Genetic Counseling for BRCA1/BRCA2 Testing. Genetic Testing 1997;1:91-8. [DOI: 10.1089/gte.1997.1.91] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
414 Dahdaleh FS, Carr JC, Calva D, Howe JR. Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet. 2012;81:110-116. [PMID: 21834858 DOI: 10.1111/j.1399-0004.2011.01763.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
415 Devenutto L, Quintana R, Quintana T. In vitro activation of ovarian cortex and autologous transplantation: A novel approach to primary ovarian insufficiency and diminished ovarian reserve. Hum Reprod Open 2020;2020:hoaa046. [PMID: 33225075 DOI: 10.1093/hropen/hoaa046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
416 Wessagowit V. Molecular Diagnosis of Genodermatoses. In: Has C, Sitaru C, editors. Molecular Dermatology. Totowa: Humana Press; 2013. pp. 33-96. [DOI: 10.1007/978-1-62703-227-8_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
417 Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, Jacob I, Harvie M, Cuzick J, Brentnall A, Wilson M, Harrison F, Payne K, Howell A. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Programme Grants Appl Res 2016;4:1-210. [DOI: 10.3310/pgfar04110] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
418 Queisser A, Seront E, Boon LM, Vikkula M. Genetic Basis and Therapies for Vascular Anomalies. Circ Res 2021;129:155-73. [PMID: 34166070 DOI: 10.1161/CIRCRESAHA.121.318145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
419 Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol 2012;36:671-87. [PMID: 22446940 DOI: 10.1097/PAS.0b013e31824dd86c] [Cited by in Crossref: 61] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
420 Levine RA, Forest T, Smith C. Tumor Suppressor PTEN is Mutated in Canine Osteosarcoma Cell Lines and Tumors. Vet Pathol 2002;39:372-8. [DOI: 10.1354/vp.39-3-372] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 14.2] [Reference Citation Analysis]
421 Maxwell, Risinger, Shaw, Alvarez, Barrett, Futreal, Berchuck. Mutations in the PTEN tumor suppressor gene in cervical carcinomas. Int J Gynecol Cancer 1998;8:489-93. [DOI: 10.1046/j.1525-1438.1998.98102.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
422 Roger PP, van Staveren WC, Coulonval K, Dumont JE, Maenhaut C. Signal transduction in the human thyrocyte and its perversion in thyroid tumors. Molecular and Cellular Endocrinology 2010;321:3-19. [DOI: 10.1016/j.mce.2009.11.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
423 Wreesmann VB, Singh B. Clinical Impact of Molecular Analysis on Thyroid Cancer Management. Surgical Oncology Clinics of North America 2008;17:1-35. [DOI: 10.1016/j.soc.2007.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
424 Ogita S, Lorusso P. Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs. Targ Oncol 2011;6:103-17. [DOI: 10.1007/s11523-011-0176-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
425 Murata J, Tada M, Sawamura Y, Mitsumori K, Abe H, Nagashima K. Dysplastic gangliocytoma (Lhermitte-Duclos disease) associated with Cowden disease: report of a case and review of the literature for the genetic relationship between the two diseases. J Neurooncol 1999;41:129-36. [PMID: 10222433 DOI: 10.1023/a:1006167421100] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
426 Li G, Robinson GW, Lesche R, Martinez-diaz H, Jiang Z, Rozengurt N, Wagner K, Wu D, Lane TF, Liu X, Hennighausen L, Wu H. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 2002;129:4159-70. [DOI: 10.1242/dev.129.17.4159] [Cited by in Crossref: 73] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
427 Eng C. PTEN: One Gene, Many Syndromes. Hum Mutat 2003;22:183-98. [DOI: 10.1002/humu.10257] [Cited by in Crossref: 587] [Cited by in F6Publishing: 502] [Article Influence: 32.6] [Reference Citation Analysis]
428 Dong L, Gao M, Hao WJ, Zheng XQ, Li YG, Li XL, Yu Y. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer. Medicine (Baltimore) 2016;95:e3695. [PMID: 27258496 DOI: 10.1097/MD.0000000000003695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
429 Zbuk KM, Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 2007;7:35-45. [PMID: 17167516 DOI: 10.1038/nrc2037] [Cited by in Crossref: 177] [Cited by in F6Publishing: 150] [Article Influence: 11.8] [Reference Citation Analysis]
430 Zhou XP, Gimm O, Hampel H, Niemann T, Walker MJ, Eng C. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol 2000;157:1123-8. [PMID: 11021816 DOI: 10.1016/S0002-9440(10)64627-5] [Cited by in Crossref: 193] [Cited by in F6Publishing: 83] [Article Influence: 9.2] [Reference Citation Analysis]
431 Fukumoto M, Ijuin T, Takenawa T. PI(3,4)P2 plays critical roles in the regulation of focal adhesion dynamics of MDA-MB-231 breast cancer cells. Cancer Sci 2017;108:941-51. [PMID: 28247964 DOI: 10.1111/cas.13215] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
432 Faro A, Boj SF, Clevers H. Fishing for intestinal cancer models: unraveling gastrointestinal homeostasis and tumorigenesis in zebrafish. Zebrafish 2009;6:361-76. [PMID: 19929219 DOI: 10.1089/zeb.2009.0617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
433 Hopkins BD, Hodakoski C, Barrows D, Mense SM, Parsons RE. PTEN function: the long and the short of it. Trends Biochem Sci 2014;39:183-90. [PMID: 24656806 DOI: 10.1016/j.tibs.2014.02.006] [Cited by in Crossref: 155] [Cited by in F6Publishing: 154] [Article Influence: 22.1] [Reference Citation Analysis]
434 Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. [PMID: 10448282 DOI: 10.1016/s0959-8049(99)00298-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
435 Lumb CN, Sansom MS. Defining the membrane-associated state of the PTEN tumor suppressor protein. Biophys J 2013;104:613-21. [PMID: 23442912 DOI: 10.1016/j.bpj.2012.12.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
436 Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. JNCI Journal of the National Cancer Institute 2013;105:1607-16. [DOI: 10.1093/jnci/djt277] [Cited by in Crossref: 285] [Cited by in F6Publishing: 204] [Article Influence: 35.6] [Reference Citation Analysis]
437 Zhang C, Cao S, Toole BP, Xu Y. Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: a model for solid-cancer initiation and early development. Int J Cancer 2015;136:2001-11. [PMID: 24828886 DOI: 10.1002/ijc.28975] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
438 Abbas A, Padmanabhan R, Eng C. Metabolic stress regulates genome-wide transcription in a PTEN-dependent manner. Hum Mol Genet 2020;29:2736-45. [PMID: 32744308 DOI: 10.1093/hmg/ddaa168] [Reference Citation Analysis]
439 Bennett IC, Gattas M, Teh BT. The management of familial breast cancer. Breast 2000;9:247-63. [PMID: 14732174 DOI: 10.1054/brst.2000.0208] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
440 Houlston R, Bevan S, Williams A, Young J, Dunlop M, Rozen P, Eng C, Markie D, Woodford-Richens K, Rodriguez-Bigas MA, Leggett B, Neale K, Phillips R, Sheridan E, Hodgson S, Iwama T, Eccles D, Bodmer W, Tomlinson I. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet 1998;7:1907-12. [PMID: 9811934 DOI: 10.1093/hmg/7.12.1907] [Cited by in Crossref: 93] [Cited by in F6Publishing: 73] [Article Influence: 4.0] [Reference Citation Analysis]
441 Li L, Liu F, Salmonsen RA, Turner TK, Litofsky NS, Di Cristofano A, Pandolfi PP, Jones SN, Recht LD, Ross AH. PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci 2002;20:21-9. [PMID: 12056837 DOI: 10.1006/mcne.2002.1115] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 4.9] [Reference Citation Analysis]
442 Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008;27:5443-53. [PMID: 18794879 DOI: 10.1038/onc.2008.241] [Cited by in Crossref: 241] [Cited by in F6Publishing: 234] [Article Influence: 18.5] [Reference Citation Analysis]
443 Hu ZI, Bangiyev L, Seidman RJ, Cohen JA. Dysphagia and Neck Swelling in a Case of Undiagnosed Lhermitte-Duclos Disease and Cowden Syndrome. Case Rep Oncol Med 2015;2015:546297. [PMID: 26448889 DOI: 10.1155/2015/546297] [Reference Citation Analysis]
444 Sozopoulos E, Litsiou H, Voutsinas G, Mitsiades N, Anagnostakis N, Tseva T, Patsouris E, Tseleni-Balafouta S. Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece. Endocr Pathol 2010;21:90-100. [PMID: 20186503 DOI: 10.1007/s12022-010-9112-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
445 Haddadi N, Travis G, Nassif NT, Simpson AM, Marsh DJ. Toward Systems Pathology for PTEN Diagnostics. Cold Spring Harb Perspect Med 2020;10:a037127. [PMID: 31615872 DOI: 10.1101/cshperspect.a037127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
446 van den Brink GR, Offerhaus GJ. The Morphogenetic Code and Colon Cancer Development. Cancer Cell 2007;11:109-17. [DOI: 10.1016/j.ccr.2007.01.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
447 Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA. 1999;96:4240-4245. [PMID: 10200246 DOI: 10.1073/pnas.96.8.4240] [Cited by in Crossref: 1395] [Cited by in F6Publishing: 1325] [Article Influence: 63.4] [Reference Citation Analysis]
448 Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet. 1997;16:333-334. [PMID: 9241266 DOI: 10.1038/ng0897-333] [Cited by in Crossref: 423] [Cited by in F6Publishing: 390] [Article Influence: 17.6] [Reference Citation Analysis]
449 Tang L, Chen F, Wang H, Hu X, Dai X, Mao J, Shen Z, Wu Y, Wang S, Hai J, Yan G, Li H, Huang J. Haplotype analysis of eight genes of the monoubiquitinated FANCD2–DNA damage–repair pathway in breast cancer patients. Cancer Epidemiology 2013;37:311-7. [DOI: 10.1016/j.canep.2012.12.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
450 Kobayashi Y, Takeda T, Kunitomi H, Ueki A, Misu K, Kowashi A, Takahashi T, Anko M, Watanabe K, Masuda K, Uchida T, Tominaga E, Banno K, Kosaki K, Aoki D. Cowden syndrome complicated by schizophrenia: A first clinical report. Eur J Med Genet 2020;63:103959. [PMID: 32461083 DOI: 10.1016/j.ejmg.2020.103959] [Reference Citation Analysis]
451 He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet. 2004;36:1117-1121. [PMID: 15378062 DOI: 10.1038/ng1430] [Cited by in Crossref: 749] [Cited by in F6Publishing: 680] [Article Influence: 44.1] [Reference Citation Analysis]
452 He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng C. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome. J Clin Endocrinol Metab 2012;97:E2179-87. [PMID: 22962422 DOI: 10.1210/jc.2012-1991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
453 Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, Chen J. WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol 2011;13:728-33. [PMID: 21532586 DOI: 10.1038/ncb2240] [Cited by in Crossref: 184] [Cited by in F6Publishing: 185] [Article Influence: 18.4] [Reference Citation Analysis]
454 Borg Å. Molecular and pathological characterization of inherited breast cancer. Seminars in Cancer Biology 2001;11:375-85. [DOI: 10.1006/scbi.2001.0393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
455 Richmond CA, Breault DT. Regulation of gene expression in the intestinal epithelium. Prog Mol Biol Transl Sci. 2010;96:207-229. [PMID: 21075346 DOI: 10.1016/b978-0-12-381280-3.00009-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
456 Pulido R, van Huijsduijnen RH. Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease: DSPs in health and disease. FEBS Journal 2008;275:848-66. [DOI: 10.1111/j.1742-4658.2008.06250.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
457 Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13:283-296. [PMID: 22473468 DOI: 10.1038/nrm3330] [Cited by in Crossref: 1129] [Cited by in F6Publishing: 1184] [Article Influence: 125.4] [Reference Citation Analysis]
458 Tsuda M, Inoue-Narita T, Suzuki A, Itami S, Blumenberg M, Manabe M. Induction of gene encoding FABP4 in Pten-null keratinocytes. FEBS Lett 2009;583:1319-22. [PMID: 19303874 DOI: 10.1016/j.febslet.2009.03.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
459 Pacheco TR, Scatena LS, Hoffenberg EJ, Gralla J, Lee LA. Café au Lait Macules and Juvénile Polyps: Café au Lait Macules and Juvénile Polyps. Pediatric Dermatology 2007;24:E17-21. [DOI: 10.1111/j.1525-1470.2007.00386.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
460 Evans DG, Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet 2002;39:865-71. [PMID: 12471197 DOI: 10.1136/jmg.39.12.865] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
461 Mehenni H, Lin-marq N, Buchet-poyau K, Reymond A, Collart MA, Picard D, Antonarakis SE. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Human Molecular Genetics 2005;14:2209-19. [DOI: 10.1093/hmg/ddi225] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 4.9] [Reference Citation Analysis]
462 Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene. 2003;22:3113-3122. [PMID: 12789288 DOI: 10.1038/sj.onc.1206451] [Cited by in Crossref: 292] [Cited by in F6Publishing: 268] [Article Influence: 16.2] [Reference Citation Analysis]
463 Malmer B, Grönberg H, Andersson U, Jonsson BA, Henriksson R. Microsatellite instability, PTEN and p53 germline mutations in glioma families. Acta Oncol. 2001;40:633-637. [PMID: 11669337 DOI: 10.1080/028418601750444196] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
464 Govender D, Chetty R. Gene of the month: PTEN. J Clin Pathol 2012;65:601-3. [PMID: 22416141 DOI: 10.1136/jclinpath-2012-200711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
465 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
466 Moore FD. Inherited aspects of papillary thyroid carcinoma: Aspects of Papillary Thyroid Carcinoma. J Surg Oncol 2006;94:719-24. [DOI: 10.1002/jso.20692] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
467 Ueda K, Nishijima M, Inui H, Watatani M, Yayoi E, Okamura J, Yasutomi M, Nakamura Y, Miyoshi Y. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers. Jpn J Cancer Res 1998;89:17-21. [PMID: 9510470 DOI: 10.1111/j.1349-7006.1998.tb00473.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
468 Dalle S, Martin-denavit T, Thomas L. Hypervariabilité génotypique des mélanomas : Un défi thérapeutique. Med Sci (Paris) 2006;22:178-82. [DOI: 10.1051/medsci/2006222178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
469 Yue F, Bi P, Wang C, Shan T, Nie Y, Ratliff TL, Gavin TP, Kuang S. Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nat Commun. 2017;8:14328. [PMID: 28094257 DOI: 10.1038/ncomms14328] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
470 Tekin M, Hişmi BO, Fitoz S, Yalçinkaya F, Ekim M, Kansu A, Ertem M, Deda G, Tutar E, Arsan S, Zhou XP, Pilarski R, Eng C, Akar N. A germline PTEN mutation with manifestations of prenatal onset and verrucous epidermal nevus. Am J Med Genet A 2006;140:1472-5. [PMID: 16752378 DOI: 10.1002/ajmg.a.31273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
471 Yang T, Zhang JS, Massa SM, Han X, Longo FM. Leukocyte common antigen-related tyrosine phosphatase receptor: Increased expression and neuronal-type splicing in breast cancer cells and tissue. Mol Carcinog 1999;25:139-49. [DOI: 10.1002/(sici)1098-2744(199906)25:2<139::aid-mc9>3.0.co;2-t] [Cited by in Crossref: 23] [Article Influence: 1.0] [Reference Citation Analysis]
472 Omur O, Baran Y. An update on molecular biology of thyroid cancers. Critical Reviews in Oncology/Hematology 2014;90:233-52. [DOI: 10.1016/j.critrevonc.2013.12.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
473 Jing J, Wang B, Liu P. The Functional Role of SEC23 in Vesicle Transportation, Autophagy and Cancer. Int J Biol Sci 2019;15:2419-26. [PMID: 31595159 DOI: 10.7150/ijbs.37008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
474 Stathopoulos P, Raymond A, Esson M. Cowden syndrome: mucocutaneous lesions as precursors of internal malignancy. Oral Maxillofac Surg 2014;18:229-35. [PMID: 24687348 DOI: 10.1007/s10006-014-0445-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
475 Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, Das S. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 2001;91:22-6. [PMID: 11149415 DOI: 10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s] [Cited by in Crossref: 187] [Cited by in F6Publishing: 75] [Article Influence: 9.4] [Reference Citation Analysis]
476 Erickson RP. Somatic gene mutation and human disease other than cancer: An update. Mutation Research/Reviews in Mutation Research 2010;705:96-106. [DOI: 10.1016/j.mrrev.2010.04.002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 10.6] [Reference Citation Analysis]
477 Freihoff D, Kempe A, Beste B, Wappenschmidt B, Kreyer E, Hayashi Y, Meindl A, Krebs D, Wiestler OD, von Deimling A, Schmutzler RK. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer 1999;79:754-8. [PMID: 10070865 DOI: 10.1038/sj.bjc.6690121] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
478 Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019;18:26. [PMID: 30782187 DOI: 10.1186/s12943-019-0954-x] [Cited by in Crossref: 294] [Cited by in F6Publishing: 297] [Article Influence: 147.0] [Reference Citation Analysis]
479 Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin Oncol 2007;34:428-34. [PMID: 17920899 DOI: 10.1053/j.seminoncol.2007.07.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 71] [Article Influence: 7.3] [Reference Citation Analysis]
480 Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proceedings of the National Academy of Sciences 2000;97:3207-12. [DOI: 10.1073/pnas.97.7.3207] [Cited by in Crossref: 229] [Cited by in F6Publishing: 151] [Article Influence: 10.9] [Reference Citation Analysis]
481 Hamila SA, Ooms LM, Rodgers SJ, Mitchell CA. The INPP4B paradox: Like PTEN, but different. Adv Biol Regul 2021;82:100817. [PMID: 34216856 DOI: 10.1016/j.jbior.2021.100817] [Reference Citation Analysis]
482 Spataro V. Recent advances in the molecular genetics of cancer. Second joint conference of the American Association of Cancer Research and the European Association of Cancer Research, Oxford, 9-12 September 1997. Ann Oncol 1998;9:23-9. [PMID: 9541679 DOI: 10.1023/a:1008263531395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
483 Bussaglia E, Pujol RM, Jesus Gil M, Martí RM, Tuneu A, Febrer MI, Garcia-patos V, Ruiz EM, Barnadas M, Alegre M, Serrano S, Matias-guiu X. PTEN Mutations in Eight Spanish Families and One Brazilian Family with Cowden Syndrome. Journal of Investigative Dermatology 2002;118:639-44. [DOI: 10.1046/j.1523-1747.2002.01728.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
484 Kolibaba KS, Druker BJ. Protein tyrosine kinases and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1997;1333:F217-48. [DOI: 10.1016/s0304-419x(97)00022-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 50] [Article Influence: 1.5] [Reference Citation Analysis]
485 Chen ST, Yu SY, Tsai M, Yeh KT, Wang JC, Kao MC, Shih MC, Chang JG. Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer. Breast Cancer Res Treat. 1999;55:85-89. [PMID: 10472782 DOI: 10.1023/a:1006142919428] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
486 Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460. [PMID: 20018966 DOI: 10.1056/NE] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
487 Gryfe R. Overview of Colorectal Cancer Genetics. Surgical Oncology Clinics of North America 2009;18:573-83. [DOI: 10.1016/j.soc.2009.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
488 Marchler-Bauer A, Addess KJ, Chappey C, Geer L, Madej T, Matsuo Y, Wang Y, Bryant SH. MMDB: Entrez's 3D structure database. Nucleic Acids Res 1999;27:240-3. [PMID: 9847190 DOI: 10.1093/nar/27.1.240] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
489 Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015;25:716-59. [PMID: 25900731 DOI: 10.1089/thy.2014.0460] [Cited by in Crossref: 472] [Cited by in F6Publishing: 370] [Article Influence: 94.4] [Reference Citation Analysis]
490 Whang YE, Yuan XJ, Liu Y, Majumder S, Lewis TD. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor. Vitam Horm. 2004;67:409-426. [PMID: 15110188 DOI: 10.1016/s0083-6729(04)67021-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
491 Cantara S, Capuano S, Capezzone M, Benigni M, Pisu M, Marchisotta S, Pacini F. Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres. Thyroid 2012;22:363-8. [PMID: 22304389 DOI: 10.1089/thy.2011.0109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
492 Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 2009;8:4072-8. [PMID: 19923889 DOI: 10.4161/cc.8.24.10242] [Cited by in Crossref: 155] [Cited by in F6Publishing: 156] [Article Influence: 12.9] [Reference Citation Analysis]
493 Rodgers SJ, Ferguson DT, Mitchell CA, Ooms LM. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Biosci Rep 2017;37:BSR20160432. [PMID: 28082369 DOI: 10.1042/BSR20160432] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
494 Chen Q, Samaranayake L, Zhou H, Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncology 2000;36:95-9. [DOI: 10.1016/s1368-8375(99)00068-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
495 Capezzone M, Robenshtok E, Cantara S, Castagna MG. Familial non-medullary thyroid cancer: a critical review. J Endocrinol Invest 2021;44:943-50. [PMID: 33025555 DOI: 10.1007/s40618-020-01435-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
496 Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. Am J Pathol 2010;176:3062-72. [PMID: 20395440 DOI: 10.2353/ajpath.2010.090872] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
497 Ball S, Arolker M, Purushotham A. Breast cancer, Cowden disease and PTEN-MATCHS syndrome. European Journal of Surgical Oncology (EJSO) 2001;27:604-6. [DOI: 10.1053/ejso.2001.1121] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
498 Choi H, Park HH, Lee KY, Choi NY, Yu HJ, Lee YJ, Park J, Huh YM, Lee SH, Koh SH. Coenzyme Q10 restores amyloid beta-inhibited proliferation of neural stem cells by activating the PI3K pathway. Stem Cells Dev 2013;22:2112-20. [PMID: 23509892 DOI: 10.1089/scd.2012.0604] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
499 Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, Ikeuchi M, Nagy A, Mak TW, Nakano T. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 2003;130:1691-700. [DOI: 10.1242/dev.00392] [Cited by in Crossref: 178] [Cited by in F6Publishing: 172] [Article Influence: 9.9] [Reference Citation Analysis]
500 Nakajima H, Sakaguchi K, Fujiwara I, Mizuta M, Tsuruga M, Magae J, Mizuta N. Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers. Biochem Biophys Res Commun 2007;356:260-5. [PMID: 17350598 DOI: 10.1016/j.bbrc.2007.02.136] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
501 Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer. 2006;118:2390-2398. [PMID: 16425225 DOI: 10.1002/ijc.21799] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
502 Marchese C, Montera M, Torrini M, Forni M, Goldoni F, Locatelli L, Mareni C. Granular cell tumor in a PHTS patient with a novel germlinePTEN mutation. Am J Med Genet 2003;120A:286-8. [DOI: 10.1002/ajmg.a.20179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
503 Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. Biochem J. 2000;346 Pt 3:827-833. [PMID: 10698713 DOI: 10.1042/0264-6021:3460827] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
504 Pinheiro M, Lupinacci FCS, Santiago KM, Drigo SA, Marchi FA, Fonseca-Alves CE, Andrade SCDS, Aagaard MM, Basso TR, Dos Reis MB, Villacis RAR, Roffé M, Hajj GNM, Jurisica I, Kowalski LP, Achatz MI, Rogatto SR. Germline Mutation in MUS81 Resulting in Impaired Protein Stability is Associated with Familial Breast and Thyroid Cancer. Cancers (Basel) 2020;12:E1289. [PMID: 32443704 DOI: 10.3390/cancers12051289] [Reference Citation Analysis]
505 Grønbæk K, Zeuthen J, Guldberg P, Ralfkiær E, Hou-jensen K. Alterations of the MMAC1/PTEN Gene in Lymphoid Malignancies. Blood 1998;91:4388-90. [DOI: 10.1182/blood.v91.11.4388] [Cited by in Crossref: 43] [Article Influence: 1.9] [Reference Citation Analysis]
506 Valvo V, Nucera C. Coding Molecular Determinants of Thyroid Cancer Development and Progression. Endocrinol Metab Clin North Am 2019;48:37-59. [PMID: 30717910 DOI: 10.1016/j.ecl.2018.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
507 Castellino RC, Durden DL. Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol 2007;3:682-93. [PMID: 18046441 DOI: 10.1038/ncpneuro0661] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
508 Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I, Chou TC, O-Charoenrat P, Levine AJ, Rao PH. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev. 2002;16:984-993. [PMID: 11959846 DOI: 10.1101/gad.973602] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 7.4] [Reference Citation Analysis]
509 Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 1997;94:14719-24. [PMID: 9405679 DOI: 10.1073/pnas.94.26.14719] [Cited by in Crossref: 285] [Cited by in F6Publishing: 250] [Article Influence: 12.4] [Reference Citation Analysis]
510 Tsun ZY, Possemato R. Amino acid management in cancer. Semin Cell Dev Biol 2015;43:22-32. [PMID: 26277542 DOI: 10.1016/j.semcdb.2015.08.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
511 Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta. 2015;1855:104-121. [PMID: 25450577 DOI: 10.1016/j.bbcan.2014.09.008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 125] [Article Influence: 9.6] [Reference Citation Analysis]
512 Cohn DE, Basil JB, Venegoni AR, Mutch DG, Rader JS, Herzog TJ, Gersell DJ, Goodfellow PJ. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability. Gynecol Oncol 2000;79:101-6. [PMID: 11006040 DOI: 10.1006/gyno.2000.5900] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
513 Allain DC. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology. J Mol Diagn. 2008;10:383-395. [PMID: 18687797 DOI: 10.2353/jmoldx.2008.070161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
514 Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C. GermlinePTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba Syndrome. Am J Med Genet 1998;80:399-402. [DOI: 10.1002/(sici)1096-8628(19981204)80:4<399::aid-ajmg18>3.0.co;2-o] [Cited by in Crossref: 72] [Article Influence: 3.1] [Reference Citation Analysis]
515 Maxwell KN, Domchek SM. Familial Breast Cancer Risk. Curr Breast Cancer Rep 2013;5:170-82. [DOI: 10.1007/s12609-013-0117-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
516 Guerra L, Castori M, Didona B, Castiglia D, Zambruno G. Hereditary palmoplantar keratodermas. Part II: syndromic palmoplantar keratodermas - Diagnostic algorithm and principles of therapy. J Eur Acad Dermatol Venereol 2018;32:899-925. [DOI: 10.1111/jdv.14834] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
517 Chmielewska JJ, Burkardt D, Granadillo JL, Slaugh R, Morgan S, Rotenberg J, Keren B, Mignot C, Escobar L, Turnpenny P, Zuteck M, Seaver LH, Ploski R, Dziembowska M, Wynshaw-Boris A, Adegbola A. PTPN4 germline variants result in aberrant neurodevelopment and growth. HGG Adv 2021;2:100033. [PMID: 34527963 DOI: 10.1016/j.xhgg.2021.100033] [Reference Citation Analysis]
518 Sandell S, Schuit RJ, Bunyan DJ. An intronic polymorphic deletion in the PTEN gene: implications for molecular diagnostic testing. Br J Cancer 2013;108:438-41. [PMID: 23299532 DOI: 10.1038/bjc.2012.562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
519 Castel P, Rauen KA, McCormick F. The duality of human oncoproteins: drivers of cancer and congenital disorders. Nat Rev Cancer 2020;20:383-97. [PMID: 32341551 DOI: 10.1038/s41568-020-0256-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
520 den Hertog J. Tumor Suppressors in Zebrafish: From TP53 to PTEN and Beyond. Adv Exp Med Biol 2016;916:87-101. [PMID: 27165350 DOI: 10.1007/978-3-319-30654-4_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
521 Kang-Park S, Lee YI, Lee YI. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells. FEBS Lett. 2003;545:203-208. [PMID: 12804776 DOI: 10.1016/s0014-5793(03)00535-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
522 Sheng WZ, Chen YS, Tu CT, He J, Zhang B, Gao WD. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer. World J Gastroenterol 2016; 22(24): 5532-5539 [PMID: 27350731 DOI: 10.3748/wjg.v22.i24.5532] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
523 Waite KA, Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Human Molecular Genetics 2003;12:679-84. [DOI: 10.1093/hmg/ddg069] [Cited by in Crossref: 68] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
524 Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis. 2007;28:1379-1386. [PMID: 17341655 DOI: 10.1093/carcin/bgm052] [Cited by in Crossref: 268] [Cited by in F6Publishing: 254] [Article Influence: 19.1] [Reference Citation Analysis]
525 Kang S, Roh JW, Kim JW. Single nucleotide polymorphism: a new risk factor for endometrial cancer? Future Oncol 2005;1:323-30. [PMID: 16556006 DOI: 10.1517/14796694.1.3.323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
526 Zhao Y, Sun Y. Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application. Neoplasia 2012;14:360-7. [PMID: 22745582 DOI: 10.1593/neo.12532] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
527 Kimmelman A, Liang BC. FAMILIAL NEUROGENIC TUMOR SYNDROMES. Hematology/Oncology Clinics of North America 2001;15:1073-84. [DOI: 10.1016/s0889-8588(05)70268-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
528 Vignot S, Faivre S, Aguirre D, Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol. 2005;16:525-537. [PMID: 15728109 DOI: 10.1093/annonc/mdi113] [Cited by in Crossref: 456] [Cited by in F6Publishing: 413] [Article Influence: 28.5] [Reference Citation Analysis]
529 Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, Yasuda A, Takahashi H, Wakasugi T, Takeyama H. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem. 2009;331:161-171. [PMID: 19437103 DOI: 10.1007/s11010-009-0154-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 8.1] [Reference Citation Analysis]
530 Hillmann P, Fabbro D. PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases. Int J Mol Sci 2019;20:E5792. [PMID: 31752127 DOI: 10.3390/ijms20225792] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
531 Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA, Eng C. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 2008;83:261-8. [PMID: 18678321 DOI: 10.1016/j.ajhg.2008.07.011] [Cited by in Crossref: 156] [Cited by in F6Publishing: 126] [Article Influence: 12.0] [Reference Citation Analysis]
532 Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Wang D, Sadee W, La Perle K, Stromberg P, Rosol TJ, Eng C, Ostrowski MC, Leone G. Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A 2010;107:5142-7. [PMID: 20194734 DOI: 10.1073/pnas.0912524107] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
533 Tamura M, Gu J, Tran H, Yamada KM. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst. 1999;91:1820-1828. [PMID: 10547389 DOI: 10.1093/jnci/91.21.1820] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 5.8] [Reference Citation Analysis]
534 Masson GR, Williams RL. Structural Mechanisms of PTEN Regulation. Cold Spring Harb Perspect Med 2020;10:a036152. [PMID: 31636093 DOI: 10.1101/cshperspect.a036152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
535 Ahmed SF, Deb S, Paul I, Chatterjee A, Mandal T, Chatterjee U, Ghosh MK. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. J Biol Chem 2012;287:15996-6006. [PMID: 22427670 DOI: 10.1074/jbc.M111.321083] [Cited by in Crossref: 100] [Cited by in F6Publishing: 67] [Article Influence: 11.1] [Reference Citation Analysis]
536 Markman B, Atzori F, Pérez-García J, Tabernero J, Baselga J. Status of PI3K inhibition and biomarker development in cancer therapeutics. Ann Oncol. 2010;21:683-691. [PMID: 19713247 DOI: 10.1093/annonc/mdp347] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 9.1] [Reference Citation Analysis]
537 Musatov S, Roberts J, Brooks AI, Pena J, Betchen S, Pfaff DW, Kaplitt MG. Inhibition of neuronal phenotype by PTEN in PC12 cells. Proc Natl Acad Sci U S A 2004;101:3627-31. [PMID: 14990793 DOI: 10.1073/pnas.0308289101] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
538 Zheng S, Chin-Sang ID. C. elegans Methods to Study PTEN. Methods Mol Biol 2016;1388:307-21. [PMID: 27033082 DOI: 10.1007/978-1-4939-3299-3_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
539 Tsao H. Update on familial cancer syndromes and the skin. Journal of the American Academy of Dermatology 2000;42:939-69. [DOI: 10.1067/mjd.2000.104681] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
540 Jacob AI, Romigh T, Waite KA, Eng C. Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma Res 2009;19:203-10. [PMID: 19478684 DOI: 10.1097/CMR.0b013e32832ccd6e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
541 Lasko P. Diabetic flies? Using Drosophila melanogaster to understand the causes of monogenic and genetically complex diseases. Clin Genet 2002;62:358-67. [PMID: 12431248 DOI: 10.1034/j.1399-0004.2002.620502.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
542 Nylén C, Mechera R, Maréchal-Ross I, Tsang V, Chou A, Gill AJ, Clifton-Bligh RJ, Robinson BG, Sywak MS, Sidhu SB, Glover AR. Molecular Markers Guiding Thyroid Cancer Management. Cancers (Basel) 2020;12:E2164. [PMID: 32759760 DOI: 10.3390/cancers12082164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
543 Mosser VA, Li Y, Quon MJ. PTEN Does Not Modulate GLUT4 Translocation in Rat Adipose Cells under Physiological Conditions. Biochemical and Biophysical Research Communications 2001;288:1011-7. [DOI: 10.1006/bbrc.2001.5876] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
544 Sansal I, Sellers WR. The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway. JCO 2004;22:2954-63. [DOI: 10.1200/jco.2004.02.141] [Cited by in Crossref: 638] [Cited by in F6Publishing: 286] [Article Influence: 37.5] [Reference Citation Analysis]
545 Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN Gene Alterations in Lymphoid Neoplasms. Blood 1998;92:3410-5. [DOI: 10.1182/blood.v92.9.3410] [Cited by in Crossref: 117] [Article Influence: 5.1] [Reference Citation Analysis]
546 Zhang C, Comai L, Johnson DL. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. Mol Cell Biol 2005;25:6899-911. [PMID: 16055704 DOI: 10.1128/MCB.25.16.6899-6911.2005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
547 Thompson JE, Thompson CB. Putting the rap on Akt. J Clin Oncol 2004;22:4217-26. [PMID: 15483033 DOI: 10.1200/JCO.2004.01.103] [Cited by in Crossref: 161] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
548 Akca H, Demiray A, Tokgun O, Yokota J. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells. Lung Cancer 2011;73:302-9. [DOI: 10.1016/j.lungcan.2011.01.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
549 Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites. FEBS Letters 2002;528:145-53. [DOI: 10.1016/s0014-5793(02)03274-x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
550 Sapkota Y, Robson P, Lai R, Cass CE, Mackey JR, Damaraju S. A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility. Eur J Hum Genet 2012;20:682-9. [PMID: 22258532 DOI: 10.1038/ejhg.2011.273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
551 Chang J, Chen Y, Perng L, Wang N, Kao M, Yang T, Chang C, Tsai C. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract. European Journal of Cancer 1999;35:647-51. [DOI: 10.1016/s0959-8049(98)00411-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
552 Chen Y, Fu F, Lin Y, Qiu L, Lu M, Zhang J, Qiu W, Yang P, Wu N, Huang M, Wang C. The precision relationships between eight GWAS-identified genetic variants and breast cancer in a Chinese population. Oncotarget 2016;7:75457-67. [PMID: 27705907 DOI: 10.18632/oncotarget.12255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
553 Gruhl SL, Sharma P, Han TS. A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report. J Med Case Rep 2018;12:353. [PMID: 30482242 DOI: 10.1186/s13256-018-1863-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
554 Longy M, Coulon V, Duboué B, David A, Larrègue M, Eng C, Amati P, Kraimps JL, Bottani A, Lacombe D, Bonneau D. Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype. J Med Genet 1998;35:886-9. [PMID: 9832032 DOI: 10.1136/jmg.35.11.886] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
555 Lee JS, Choi YD, Lee JH, Nam JH, Choi C, Lee MC, Park CS, Kim HS, Min KW. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. J Surg Oncol 2006;93:233-40. [PMID: 16482604 DOI: 10.1002/jso.20493] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
556 Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6:58-64. [PMID: 23756719 DOI: 10.1016/j.hemonc.2013.05.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
557 Ke B, Shen XD, Ji H, Kamo N, Gao F, Freitas MC, Busuttil RW, Kupiec-Weglinski JW. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. J Hepatol. 2012;56:359-366. [PMID: 21756853 DOI: 10.1016/j.jhep.2011.05.023] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 7.1] [Reference Citation Analysis]
558 Tsao, Sober. Multiple lipomatosis in a patient with familial atypical mole syndrome: Correspondence. British Journal of Dermatology 1998;139:1118-9. [DOI: 10.1046/j.1365-2133.1998.2576g.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
559 Zhou X, Sanson M, Hoang-xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre J, Thomas G, Hamelin R; the ANOCEF Group. Germline mutations ofp53 but notp16/CDKN2 orPTEN/MMAC1 tumor suppressor genes predispose to gliomas. Ann Neurol 1999;46:913-6. [DOI: 10.1002/1531-8249(199912)46:6<913::aid-ana15>3.0.co;2-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
560 Di Cosimo S, Baselga J. Targeted therapies in breast cancer: Where are we now? European Journal of Cancer 2008;44:2781-90. [DOI: 10.1016/j.ejca.2008.09.026] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
561 Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Møller P, King MC. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet 1997;61:1254-60. [PMID: 9399897 DOI: 10.1086/301639] [Cited by in Crossref: 171] [Cited by in F6Publishing: 159] [Article Influence: 7.4] [Reference Citation Analysis]
562 Han W, Ming M, He TC, He YY. Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem 2010;285:11369-77. [PMID: 20154081 DOI: 10.1074/jbc.M109.028142] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
563 Weitzel JN. The current social, political, and medical role of genetic testing in familial breast and ovarian carcinomas: . Current Opinion in Obstetrics and Gynaecology 1999;11:65-70. [DOI: 10.1097/00001703-199901000-00012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
564 He L, Fan C, Kapoor A, Ingram AJ, Rybak AP, Austin RC, Dickhout J, Cutz JC, Scholey J, Tang D. α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells. Nat Commun 2011;2:307. [PMID: 21556061 DOI: 10.1038/ncomms1309] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
565 Faisal Ahmed S, Marsh DJ, Weremowicz S, Morton CC, Williams DM, Eng C. Balanced translocation of 10q and13q, including the PTEN gene, in a boy with a human chorionic gonadotropin-secreting tumor and the Bannayan-Riley-Ruvalcaba syndrome. J Clin Endocrinol Metab 1999;84:4665-70. [PMID: 10599735 DOI: 10.1210/jcem.84.12.6178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
566 Gil EB, Malone Link E, Liu LX, Johnson CD, Lees JA. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci U S A 1999;96:2925-30. [PMID: 10077613 DOI: 10.1073/pnas.96.6.2925] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 4.5] [Reference Citation Analysis]
567 Mutti NS, Wang Y, Kaftanoglu O, Amdam GV. Honey bee PTEN--description, developmental knockdown, and tissue-specific expression of splice-variants correlated with alternative social phenotypes. PLoS One 2011;6:e22195. [PMID: 21779392 DOI: 10.1371/journal.pone.0022195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
568 Schofied AC, Payne S, Ross VG, Miller ID, Heys SD, Haites NE. Immunohistochemical detection of a germline BRCA1 mutation in a breast and ovarian cancer family. Breast 2000;9:286-91. [PMID: 14732180 DOI: 10.1054/brst.1999.0090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
569 Nosé V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol 2010;17:428-36. [PMID: 20966648 DOI: 10.1097/PAP.0b013e3181f8b028] [Cited by in Crossref: 40] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
570 Fackenthal JD, Marsh DJ, Richardson AL, Cummings SA, Eng C, Robinson BG, Olopade OI. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001;38:159-64. [PMID: 11238682 DOI: 10.1136/jmg.38.3.159] [Cited by in Crossref: 122] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
571 Tanwar PS, Kaneko-Tarui T, Zhang L, Teixeira JM. Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis. Hum Mol Genet 2012;21:4394-405. [PMID: 22791749 DOI: 10.1093/hmg/dds272] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
572 Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, Ohnishi H, Kato Z, Sekinaka Y, Zaha K, Kato T, Okano T, Takashima T, Kobayashi K, Kimura M, Kunitsu T, Maruo Y, Kanegane H, Takagi M, Yoshida K, Okuno Y, Muramatsu H, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Kojima S, Ogawa S, Ohara O, Okada S, Kobayashi M, Morio T, Nonoyama S. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency. J Allergy Clin Immunol 2016;138:1672-1680.e10. [PMID: 27426521 DOI: 10.1016/j.jaci.2016.03.055] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
573 Fujii GH, Morimoto AM, Berson AE, Bolen JB. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene 1999;18:1765-9. [PMID: 10208437 DOI: 10.1038/sj.onc.1202492] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
574 Elo JP, Visakorpi T. Molecular genetics of prostate cancer. Annals of Medicine 2009;33:130-41. [DOI: 10.3109/07853890109002068] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
575 Smith A, Ashworth A. Cancer predisposition: where's the phosphate? Curr Biol 1998;8:R241-3. [PMID: 9545192 DOI: 10.1016/s0960-9822(98)70150-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
576 Olschwang S, Markie D, Seal S, Neale K, Phillips R, Cottrell S, Ellis I, Hodgson S, Zauber P, Spigelman A. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet. 1998;35:42-44. [PMID: 9475093 DOI: 10.1136/jmg.35.1.42] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
577 Günzl P, Schabbauer G. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties. Immunobiology. 2008;213:759-765. [PMID: 18926291 DOI: 10.1016/j.imbio.2008.07.028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
578 Zeng N, Bayan JA, He L, Stiles B. The Role of PTEN in β-Cell Growth. Open Endocrinol J 2010;4:23-32. [PMID: 23853672 DOI: 10.2174/1874216501004010023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
579 Houlston RS, Tomlinson IP. Genetic prognostic markers in colorectal cancer. Mol Pathol 1997;50:281-8. [PMID: 9536276 DOI: 10.1136/mp.50.6.281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
580 Vazquez F, Ramaswamy S, Nakamura N, Sellers WR. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 2000;20:5010-8. [PMID: 10866658 DOI: 10.1128/MCB.20.14.5010-5018.2000] [Cited by in Crossref: 548] [Cited by in F6Publishing: 283] [Article Influence: 26.1] [Reference Citation Analysis]
581 Gimm O, Chi H, Dahia PL, Perren A, Hinze R, Komminoth P, Dralle H, Reynolds PR, Eng C. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1801-5. [PMID: 11297621 DOI: 10.1210/jcem.86.4.7419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
582 Kosmas K, Mitropoulou G, Provatas I, Stamoulas M, Marouga A. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma. Cytopathology 2018;29:558-64. [PMID: 30007089 DOI: 10.1111/cyt.12612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
583 Lin G, Aranda V, Muthuswamy SK, Tonks NK. Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'. Genes Dev 2011;25:1412-25. [PMID: 21724833 DOI: 10.1101/gad.2018911] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
584 Clark AS, Domchek SM. Clinical Management of Hereditary Breast Cancer Syndromes. J Mammary Gland Biol Neoplasia 2011;16:17-25. [DOI: 10.1007/s10911-011-9200-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
585 Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J, Kirchhoff T, Gold B, Christman MF, Offit K, Gerald WL, Notterman DA, Ott J, Paty PB, Barany F. The signatures of autozygosity among patients with colorectal cancer. Cancer Res 2008;68:2610-21. [PMID: 18375840 DOI: 10.1158/0008-5472.CAN-07-5250] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
586 Pérez-ramírez C, Cañadas-garre M, Molina MÁ, Faus-dáder MJ, Calleja-hernández MÁ. PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 2015;16:1843-62. [DOI: 10.2217/pgs.15.122] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 17.3] [Reference Citation Analysis]
587 Lee DA, Grossman ME, Schneiderman P, Celebi JT. Genetics of skin appendage neoplasms and related syndromes. J Med Genet 2005;42:811-9. [PMID: 16272260 DOI: 10.1136/jmg.2004.025577] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
588 Pulido R. PTEN: a yin-yang master regulator protein in health and disease. Methods 2015;77-78:3-10. [PMID: 25843297 DOI: 10.1016/j.ymeth.2015.02.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
589 Chen Y, van de Vijver MJ, Hibshoosh H, Parsons R, Saal LH. PTEN and NEDD4 in Human Breast Carcinoma. Pathol Oncol Res 2016;22:41-7. [PMID: 26276352 DOI: 10.1007/s12253-015-9971-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
590 Padula SL, Anand D, Hoang TV, Chaffee BR, Liu L, Liang C, Lachke SA, Robinson ML. High-throughput transcriptome analysis reveals that the loss of Pten activates a novel NKX6-1/RASGRP1 regulatory module to rescue microphthalmia caused by Fgfr2-deficient lenses. Hum Genet 2019;138:1391-407. [PMID: 31691004 DOI: 10.1007/s00439-019-02084-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
591 Vazquez F, Sellers WR. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 2000;1470:M21-35. [PMID: 10656987 DOI: 10.1016/s0304-419x(99)00032-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 62] [Article Influence: 1.0] [Reference Citation Analysis]
592 Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005;42:267-333. [PMID: 15900295 DOI: 10.1067/j.cpsurg.2005.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
593 Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, Dasouki M, Feldman GL, Greenberg LA, Ivanovich J, Matloff E, Patterson A, Pierpont ME, Russo D, Nassif NT, Eng C. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003;73:404-11. [PMID: 12844284 DOI: 10.1086/377109] [Cited by in Crossref: 205] [Cited by in F6Publishing: 158] [Article Influence: 11.4] [Reference Citation Analysis]
594 Patterson AR, Leitch AM, Weatherall P, Zhou X, Eng C, Tomlinson GE. CASE 4. Fibrocystic Breast Disease in a 16-Year-Old Female With PTEN Hamartoma Tumor Syndrome. JCO 2006;24:525-7. [DOI: 10.1200/jco.2004.01.0447] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
595 Romano C, Schepis C. PTEN gene: a model for genetic diseases in dermatology. ScientificWorldJournal 2012;2012:252457. [PMID: 22623890 DOI: 10.1100/2012/252457] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
596 Zhang J, Zhang P, Wei Y, Piao HL, Wang W, Maddika S, Wang M, Chen D, Sun Y, Hung MC, Chen J, Ma L. Deubiquitylation and stabilization of PTEN by USP13. Nat Cell Biol 2013;15:1486-94. [PMID: 24270891 DOI: 10.1038/ncb2874] [Cited by in Crossref: 102] [Cited by in F6Publishing: 102] [Article Influence: 12.8] [Reference Citation Analysis]
597 Bennett IC, Gattas M, Teh BT. The genetic basis of breast cancer and its clinical implications. Aust N Z J Surg 1999;69:95-105. [PMID: 10030809 DOI: 10.1046/j.1440-1622.1999.01515.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
598 Culler D, Grimes SJ, Acheson LS, Wiesner GL. Cancer genetics in primary care. Primary Care: Clinics in Office Practice 2004;31:649-83. [DOI: 10.1016/j.pop.2004.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
599 Segev DL, Umbricht C, Zeiger MA. Molecular pathogenesis of thyroid cancer. Surgical Oncology 2003;12:69-90. [DOI: 10.1016/s0960-7404(03)00037-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
600 Perriard J, Saurat J, Harms M. An overlap of Cowden?s disease and Bannayan-Riley-Ruvalcaba syndrome in the same family. Journal of the American Academy of Dermatology 2000;42:348-50. [DOI: 10.1016/s0190-9622(00)90109-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
601 Aveyard JS, Skilleter A, Habuchi T, Knowles MA. Somatic mutation of PTEN in bladder carcinoma. Br J Cancer 1999;80:904-8. [PMID: 10360673 DOI: 10.1038/sj.bjc.6690439] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 4.4] [Reference Citation Analysis]
602 Facher EA, Law JC. PTEN and prostate cancer. J Med Genet 1998;35:790. [PMID: 9733047 DOI: 10.1136/jmg.35.9.790-a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
603 Tate G, Suzuki T, Mitsuya T. Mutation of the PTEN gene in a human hepatic angiosarcoma. Cancer Genetics and Cytogenetics 2007;178:160-2. [DOI: 10.1016/j.cancergencyto.2007.07.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
604 Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet. 2002;70:829-844. [PMID: 11875759 DOI: 10.1086/340026] [Cited by in Crossref: 313] [Cited by in F6Publishing: 272] [Article Influence: 16.5] [Reference Citation Analysis]
605 Bott SR, Arya M, Shergill IS, Williamson M. Molecular changes in prostatic cancer. Surg Oncol 2005;14:91-104. [PMID: 15993579 DOI: 10.1016/j.suronc.2005.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
606 Ess KC. The neurobiology of tuberous sclerosis complex. Semin Pediatr Neurol 2006;13:37-42. [PMID: 16818174 DOI: 10.1016/j.spen.2006.01.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
607 Miki H, Funato Y. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. Journal of Biochemistry 2012;151:255-61. [DOI: 10.1093/jb/mvs006] [Cited by in Crossref: 149] [Cited by in F6Publishing: 121] [Article Influence: 16.6] [Reference Citation Analysis]
608 Siraj AK, Masoodi T, Bu R, Beg S, Al-Sobhi SS, Al-Dayel F, Al-Dawish M, Alkuraya FS, Al-Kuraya KS. Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis. Am J Hum Genet 2016;98:1170-80. [PMID: 27236916 DOI: 10.1016/j.ajhg.2016.04.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
609 Lee Y, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol 2018;19:547-62. [DOI: 10.1038/s41580-018-0015-0] [Cited by in Crossref: 265] [Cited by in F6Publishing: 259] [Article Influence: 88.3] [Reference Citation Analysis]
610 Stewart AL, Mhashilkar AM, Yang XH, Ekmekcioglu S, Saito Y, Sieger K, Schrock R, Onishi E, Swanson X, Mumm JB, Zumstein L, Watson GJ, Snary D, Roth JA, Grimm EA, Ramesh R, Chada S. PI3K Blockade by Ad-PTEN Inhibits Invasion and Induces Apoptosis in Radial Growth Phase and Metastatic Melanoma Cells. Mol Med 2002;8:451-61. [DOI: 10.1007/bf03402025] [Cited by in Crossref: 63] [Article Influence: 3.3] [Reference Citation Analysis]
611 Dunlop E, Tee A. Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms. Cellular Signalling 2009;21:827-35. [DOI: 10.1016/j.cellsig.2009.01.012] [Cited by in Crossref: 175] [Cited by in F6Publishing: 174] [Article Influence: 14.6] [Reference Citation Analysis]
612 Li N, Zhang Y, Han X, Liang K, Wang J, Feng L, Wang W, Songyang Z, Lin C, Yang L, Yu Y, Chen J. Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth. Genes Dev 2015;29:157-70. [PMID: 25547115 DOI: 10.1101/gad.251785.114] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
613 Dralle H, Machens A, Lorenz K. [Hereditary thyroid cancer]. Chirurg 2008;79:1017-28. [PMID: 18818894 DOI: 10.1007/s00104-008-1558-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
614 Freed D, Stevens EL, Pevsner J. Somatic mosaicism in the human genome. Genes (Basel) 2014;5:1064-94. [PMID: 25513881 DOI: 10.3390/genes5041064] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
615 Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, Cho H, Song J. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun 2015;6:7769. [PMID: 26183061 DOI: 10.1038/ncomms8769] [Cited by in Crossref: 82] [Cited by in F6Publishing: 93] [Article Influence: 13.7] [Reference Citation Analysis]
616 Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. 3,3′-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochemical and Biophysical Research Communications 2006;340:718-25. [DOI: 10.1016/j.bbrc.2005.12.059] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
617 Waite KA, Sinden MR, Eng C. Phytoestrogen exposure elevates PTEN levels. Hum Mol Genet. 2005;14:1457-1463. [PMID: 15829497 DOI: 10.1093/hmg/ddi155] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
618 Yehia L, Niazi F, Ni Y, Ngeow J, Sankunny M, Liu Z, Wei W, Mester JL, Keri RA, Zhang B, Eng C. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. Am J Hum Genet 2015;97:661-76. [PMID: 26522472 DOI: 10.1016/j.ajhg.2015.10.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
619 Sasaoka T, Wada T, Tsuneki H. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol Ther 2006;112:799-809. [PMID: 16842857 DOI: 10.1016/j.pharmthera.2006.06.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
620 Neben CL, Lo M, Jura N, Klein OD. Feedback regulation of RTK signaling in development. Dev Biol 2019;447:71-89. [PMID: 29079424 DOI: 10.1016/j.ydbio.2017.10.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
621 Freeman DJ, Li AG, Wei G, Li H, Kertesz N, Lesche R, Whale AD, Martinez-diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003;3:117-30. [DOI: 10.1016/s1535-6108(03)00021-7] [Cited by in Crossref: 334] [Cited by in F6Publishing: 182] [Article Influence: 18.6] [Reference Citation Analysis]
622 Çelebi JT, Chen FF, Zhang H, Ping XL, Tsou HC, Peacocke M. Identification of PTEN mutations in five families with Bannayan-Zonana syndrome. Exp Dermatol 1999;8:134-9. [DOI: 10.1111/j.1600-0625.1999.tb00361.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
623 Bass AJ, Meyerson M. Genome-wide association study in esophageal squamous cell carcinoma. Gastroenterology 2009;137:1573-6. [PMID: 19789091 DOI: 10.1053/j.gastro.2009.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
624 Houlston RS. What we could do now: molecular pathology of colorectal cancer. Mol Pathol 2001;54:206-14. [PMID: 11477132 DOI: 10.1136/mp.54.4.206] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
625 Ngeow J, Eng C. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 2015;77-78:11-9. [PMID: 25461771 DOI: 10.1016/j.ymeth.2014.10.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
626 Innella G, Miccoli S, Colussi D, Pradella LM, Amato LB, Zuntini R, Salfi NCM, Collina G, Ferrara F, Ricciardiello L, Turchetti D. Colorectal polyposis as a clue to the diagnosis of Cowden syndrome: Report of two cases and literature review. Pathol Res Pract 2021;218:153339. [PMID: 33482532 DOI: 10.1016/j.prp.2020.153339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Carnero A. Novel inhibitors of the PI3K family. Expert Opinion on Investigational Drugs 2009;18:1265-77. [DOI: 10.1517/13543780903066798] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
628 McCubrey JA, Sokolosky ML, Lehmann BD, Taylor JR, Navolanic PM, Chappell WH, Abrams SL, Stadelman KM, Wong EW, Misaghian N, Horn S, Bäsecke J, Libra M, Stivala F, Ligresti G, Tafuri A, Milella M, Zarzycki M, Dzugaj A, Chiarini F, Evangelisti C, Martelli AM, Terrian DM, Franklin RA, Steelman LS. Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy. Adv Enzyme Regul 2008;48:113-35. [PMID: 18423407 DOI: 10.1016/j.advenzreg.2008.02.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
629 Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. [PMID: 10448282 DOI: 10.1016/s0959-8049(98)00431-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
630 McKenna M, McGarrigle S, Pidgeon GP. The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts. Biochim Biophys Acta Rev Cancer. 2018;1870:185-197. [PMID: 30318472 DOI: 10.1016/j.bbcan.2018.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
631 Pitta K, Krishnan M. Molecular Mechanism, Dynamics, and Energetics of Protein-Mediated Dinucleotide Flipping in a Mismatched DNA: A Computational Study of the RAD4-DNA Complex. J Chem Inf Model 2018;58:647-60. [PMID: 29474070 DOI: 10.1021/acs.jcim.7b00636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
632 Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell. 2003;11:1457-1466. [PMID: 12820960 DOI: 10.1016/s1097-2765(03)00220-x] [Cited by in Crossref: 702] [Cited by in F6Publishing: 389] [Article Influence: 39.0] [Reference Citation Analysis]
633 Kohno T, Takahashi M, Manda R, Yokota J. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 1998;22:152-6. [PMID: 9598803 DOI: 10.1002/(sici)1098-2264(199806)22:2<152::aid-gcc10>3.0.co;2-s] [Cited by in Crossref: 99] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
634 Zhang J, Xiao Y, Guo Y, Breslin P, Zhang S, Wei W, Zhang Z, Zhang J. Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice. Leukemia 2011;25:1857-68. [PMID: 21926961 DOI: 10.1038/leu.2011.220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
635 Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, Lees JA, Heitz PU, Eng C. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 2000;157:1097-103. [PMID: 11021813 DOI: 10.1016/S0002-9440(10)64624-X] [Cited by in Crossref: 194] [Cited by in F6Publishing: 83] [Article Influence: 9.2] [Reference Citation Analysis]
636 Yehia L, Eng C. Largescale population genomics versus deep phenotyping: Brute force or elegant pragmatism towards precision medicine. NPJ Genom Med 2019;4:6. [PMID: 30937181 DOI: 10.1038/s41525-019-0080-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
637 Chen HJ, Romigh T, Sesock K, Eng C. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome. Hum Mutat 2017;38:1372-7. [PMID: 28677221 DOI: 10.1002/humu.23288] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
638 M JR, S V. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. Gene 2018;678:302-11. [PMID: 30096458 DOI: 10.1016/j.gene.2018.08.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
639 Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 2006;6:184-192. [PMID: 16453012 DOI: 10.1038/nrc1819] [Cited by in Crossref: 872] [Cited by in F6Publishing: 787] [Article Influence: 58.1] [Reference Citation Analysis]
640 Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-vu C, Raue F, Hinze R, Dralle H, Eng C. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene 1999;18:1369-73. [DOI: 10.1038/sj.onc.1202418] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 3.7] [Reference Citation Analysis]
641 Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M. Thyroid pathologic findings in patients with Cowden disease. Annals of Diagnostic Pathology 1999;3:331-40. [DOI: 10.1016/s1092-9134(99)80011-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
642 Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998;95:29-39. [PMID: 9778245 DOI: 10.1016/s0092-8674(00)81780-8] [Cited by in Crossref: 1689] [Cited by in F6Publishing: 796] [Article Influence: 73.4] [Reference Citation Analysis]
643 Fackrell K, Bobins L, Parul, Tomida J. FAM35A/SHLD2/RINN2: A novel determinant of double strand break repair pathway choice and genome stability in cancer. Environ Mol Mutagen 2020;61:709-15. [PMID: 32306447 DOI: 10.1002/em.22379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
644 Liu TC, Lin PM, Chang JG, Lee JP, Chen TP, Lin SF. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am J Hematol 2000;63:170-5. [PMID: 10706759 DOI: 10.1002/(sici)1096-8652(200004)63:4<170::aid-ajh2>3.0.co;2-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
645 Clendenning M, Young JP, Walsh MD, Woodall S, Arnold J, Jenkins M, Win AK, Hopper JL, Sweet K, Gallinger S, Rosty C, Parry S, Buchanan DD. Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome. PLoS One 2013;8:e66705. [PMID: 23805267 DOI: 10.1371/journal.pone.0066705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
646 Wang WC, Hou TC, Kuo CY, Lai YC. Hints from a Female Patient with Breast Cancer Who Later Presented with Cowden Syndrome. J Breast Cancer 2020;23:430-7. [PMID: 32908792 DOI: 10.4048/jbc.2020.23.e25] [Reference Citation Analysis]
647 Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK. The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci U S A 1998;95:14950-5. [PMID: 9843996 DOI: 10.1073/pnas.95.25.14950] [Cited by in Crossref: 196] [Cited by in F6Publishing: 206] [Article Influence: 8.9] [Reference Citation Analysis]
648 Wang J, Huang T, Chen F, Hsieh M, Lin S, Hou M, Hsieh J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch 2003;442:437-43. [DOI: 10.1007/s00428-003-0803-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
649 Nishizaki T, Ozaki S, Harada K, Ito H, Arai H, Beppu T, Sasaki K. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 1998;21:340-6. [PMID: 9559346 DOI: 10.1002/(sici)1098-2264(199804)21:4<340::aid-gcc8>3.0.co;2-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
650 Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002;955:281-92; discussion 293-5, 396-406. [PMID: 11949955 DOI: 10.1111/j.1749-6632.2002.tb02788.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 5.2] [Reference Citation Analysis]
651 Cameselle-Teijeiro J, Ruiz-Ponte C, Loidi L, Suarez-Peñaranda J, Baltar J, Sobrinho-Simoes M. Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma. Am J Clin Pathol 2001;115:486-93. [PMID: 11293895 DOI: 10.1309/T9CC-JNMD-1WGP-YPAF] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
652 Abdel-Rahman WM, Peltomäki P. Molecular basis and diagnostics of hereditary colorectal cancers. Ann Med 2004;36:379-88. [PMID: 15478312 DOI: 10.1080/07853890410018222] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
653 Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, Xenarios I, Zelante L, Merla G, Reymond A. TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat 2014;35:447-51. [PMID: 24515783 DOI: 10.1002/humu.22529] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
654 Maraghelli D, Giusti F, Marini F, Brandi ML. Bone tissue and mineral metabolism in hereditary endocrine tumors: clinical manifestations and genetic bases. Orphanet J Rare Dis 2020;15:102. [PMID: 32326947 DOI: 10.1186/s13023-020-01380-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
655 Nizialek EA, Peterson C, Mester JL, Downes-Kelly E, Eng C. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest. Hum Mol Genet 2013;22:2451-61. [PMID: 23446638 DOI: 10.1093/hmg/ddt097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
656 Zhang Z. Protein-Tyrosine Phosphatases: Biological Function, Structural Characteristics, and Mechanism of Catalysis. Critical Reviews in Biochemistry and Molecular Biology 2008;33:1-52. [DOI: 10.1080/10409239891204161] [Cited by in Crossref: 186] [Cited by in F6Publishing: 181] [Article Influence: 14.3] [Reference Citation Analysis]
657 He J, de la Monte S, Wands JR. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling. Biochem Biophys Res Commun 2010;397:513-9. [PMID: 20515662 DOI: 10.1016/j.bbrc.2010.05.146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
658 Liu Y, Bankaitis VA. Phosphoinositide phosphatases in cell biology and disease. Prog Lipid Res 2010;49:201-17. [PMID: 20043944 DOI: 10.1016/j.plipres.2009.12.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
659 Morimoto AM, Berson AE, Fujii GH, Teng DH, Tavtigian SV, Bookstein R, Steck PA, Bolen JB. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene. 1999;18:1261-1266. [PMID: 10022807 DOI: 10.1038/sj.onc.1202441] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
660 Wilson MA, Nathanson KL. Molecular testing in melanoma. Cancer J 2012;18:117-23. [PMID: 22453011 DOI: 10.1097/PPO.0b013e31824f11bf] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
661 Strumane K, Song J, Baas I, Collard JG. Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency. Leukemia Research 2008;32:113-20. [DOI: 10.1016/j.leukres.2007.03.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
662 Piccione M, Fragapane T, Antona V, Giachino D, Cupido F, Corsello G. PTEN hamartoma tumor syndromes in childhood: Description of two cases and a proposal for follow-up protocol. Am J Med Genet 2013;161:2902-8. [DOI: 10.1002/ajmg.a.36266] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
663 Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C. Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery 2012;152:1201-10. [PMID: 23158187 DOI: 10.1016/j.surg.2012.08.055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
664 Sobol A, Galluzzo P, Weber MJ, Alani S, Bocchetta M. Depletion of Amyloid Precursor Protein (APP) causes G0 arrest in non-small cell lung cancer (NSCLC) cells. J Cell Physiol 2015;230:1332-41. [PMID: 25502341 DOI: 10.1002/jcp.24875] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
665 Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem. 2002;277:5484-5489. [PMID: 11729185 DOI: 10.1074/jbc.m108302200] [Cited by in Crossref: 233] [Cited by in F6Publishing: 92] [Article Influence: 11.7] [Reference Citation Analysis]
666 Pereiro P, Figueras A, Novoa B. Zebrafish pten Genes Play Relevant but Distinct Roles in Antiviral Immunity. Vaccines (Basel) 2020;8:E199. [PMID: 32357549 DOI: 10.3390/vaccines8020199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
667 Salo-Mullen EE, Shia J, Brownell I, Allen P, Girotra M, Robson ME, Offit K, Guillem JG, Markowitz AJ, Stadler ZK. Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. Fam Cancer 2014;13:459-67. [PMID: 24609522 DOI: 10.1007/s10689-014-9709-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
668 Agarwal V, Campbell A, Beaumont KL, Cawkwell L, Lind MJ. PTEN protein expression in malignant pleural mesothelioma. Tumour Biol 2013;34:847-51. [PMID: 23242608 DOI: 10.1007/s13277-012-0615-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
669 Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, von Deimling A. Comparative analysis of theNF2, TP53, PTEN, KRAS, NRAS andHRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 2001;94:218-21. [DOI: 10.1002/ijc.1467] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
670 Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM. PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene. 1999;18:3181-3185. [PMID: 10340391 DOI: 10.1038/sj.onc.1202659] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 3.5] [Reference Citation Analysis]
671 Orloff MS, He X, Peterson C, Chen F, Chen JL, Mester JL, Eng C. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am J Hum Genet 2013;92:76-80. [PMID: 23246288 DOI: 10.1016/j.ajhg.2012.10.021] [Cited by in Crossref: 132] [Cited by in F6Publishing: 104] [Article Influence: 14.7] [Reference Citation Analysis]
672 Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ, Chi SG. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. Int J Cancer. 2003;104:318-327. [PMID: 12569555 DOI: 10.1002/ijc.10962] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 7.6] [Reference Citation Analysis]
673 Shi BH, Nashimoto T, Andoh R, Konishi H, Kobayashi M, Xu Q, Ihara S, Fukui Y. Mutation of the PI3' kinase gene in a human colon carcinoma cell line, HCC2998. DNA Cell Biol 2006;25:399-405. [PMID: 16848681 DOI: 10.1089/dna.2006.25.399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
674 Ngeow J, Eng C. PTEN in Hereditary and Sporadic Cancer. Cold Spring Harb Perspect Med 2020;10:a036087. [PMID: 31570378 DOI: 10.1101/cshperspect.a036087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
675 Xu W, Yang Z, Zhou SF, Lu N. Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors. Drug Des Devel Ther 2014;8:1745-51. [PMID: 25336918 DOI: 10.2147/DDDT.S71061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
676 Dobson ME, Diallo-Krou E, Grachtchouk V, Yu J, Colby LA, Wilkinson JE, Giordano TJ, Koenig RJ. Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma. Endocrinology 2011;152:4455-65. [PMID: 21952241 DOI: 10.1210/en.2011-1178] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
677 Ren J, Wang B, Li J. Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer. BMC Syst Biol 2018;12:130. [PMID: 30577793 DOI: 10.1186/s12918-018-0646-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
678 Warren R. Screening women at high risk of breast cancer on the basis of evidence. European Journal of Radiology 2001;39:50-9. [DOI: 10.1016/s0720-048x(00)00237-0] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
679 Yao D, Alexander CL, Quinn JA, Chan W, Wu H, Greenhalgh DA. Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21WAF-induced differentiation triggered by GSK3β inactivation and reduced AKT activity. Journal of Cell Science 2008;121:1758-69. [DOI: 10.1242/jcs.021147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
680 Liu Y, Malaviarachchi P, Beggs M, Emanuel PD. PTEN transcript variants caused by illegitimate splicing in "aged" blood samples and EBV-transformed cell lines. Hum Genet 2010;128:609-14. [PMID: 20839010 DOI: 10.1007/s00439-010-0886-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
681 Reinbolt RE, Hays JL. The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies. Front Oncol 2013;3:237. [PMID: 24098868 DOI: 10.3389/fonc.2013.00237] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
682 Vella V, Puppin C, Damante G, Vigneri R, Sanfilippo M, Vigneri P, Tell G, Frasca F. DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells. Int J Cancer 2009;124:2539-48. [PMID: 19173293 DOI: 10.1002/ijc.24221] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
683 Otto LR, Boriack RL, Marsh DJ, Kum JB, Eng C, Burlina AB, Bennett MJ. Long-chain L 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency does not appear to be the primary cause of lipid myopathy in patients with Bannayan-Riley-Ruvalcaba syndrome (BRRS). Am J Med Genet 1999;83:3-5. [DOI: 10.1002/(sici)1096-8628(19990305)83:1<3::aid-ajmg2>3.0.co;2-k] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
684 He X, Thacker S, Romigh T, Yu Q, Frazier TW Jr, Eng C. Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits. Mol Autism 2015;6:63. [PMID: 26579216 DOI: 10.1186/s13229-015-0056-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
685 Olsson H. A hypothesis about tumour development and the clinical features of hereditary breast cancers. Eur J Cancer 2001;37:2023-9. [PMID: 11597380 DOI: 10.1016/s0959-8049(01)00228-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
686 Golas MM, Auber B, Ripperger T, Pabst B, Schmidt G, Morlot M, Diebold U, Steinemann D, Schlegelberger B, Morlot S. Looking for the hidden mutation: Bannayan-Riley-Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A. Am J Med Genet A 2019;179:1383-9. [PMID: 31062505 DOI: 10.1002/ajmg.a.61166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
687 Hong T, Yang P, Peck K, Chen JJW, Yang S, Chen Y, Wu C. Profiling the Downstream Genes of Tumor Suppressor PTEN in Lung Cancer Cells by Complementary DNA Microarray. Am J Respir Cell Mol Biol 2000;23:355-63. [DOI: 10.1165/ajrcmb.23.3.4002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
688 Kim MK. Novel insight into the function of tankyrase. Oncol Lett 2018;16:6895-902. [PMID: 30546421 DOI: